| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.845 | 0.003 | 0.845 | 5 Hydroxytryptamine release inhibitor | 0.697 0.004 DBMET02417 0.667 0.005 DBMET02419 0.661 0.005 DBMET02420 0.439 0.056 DBMET02421 | ||
| 0.827 | 0.002 | 0.893 | Alcohol oxidase inhibitor | 0.137 0.012 DBMET02417 0.878 0.002 DBMET02419 0.893 0.002 DBMET02420 0.256 0.005 DBMET02421 | DBMET02420 | |
| 0.697 | 0.005 | 0.697 | Histamine release inhibitor | 0.694 0.005 DBMET02417 0.636 0.007 DBMET02419 0.632 0.008 DBMET02420 0.48 0.036 DBMET02421 | ||
| 0.672 | 0.003 | 0.797 | Alpha-N-acetylglucosaminidase inhibitor | 0.797 0.002 DBMET02417 0.735 0.003 DBMET02419 0.699 0.003 DBMET02420 0.373 0.01 DBMET02421 | DBMET02417 | |
| 0.674 | 0.01 | 0.745 | Cholesterol antagonist | 0.745 0.005 DBMET02417 0.65 0.012 DBMET02419 0.653 0.012 DBMET02420 0.405 0.048 DBMET02421 | DBMET02417 | |
| 0.678 | 0.035 | 0.865 | Antiinflammatory | 0.865 0.008 DBMET02417 0.63 0.045 DBMET02419 0.669 0.037 DBMET02420 | DBMET02417 | |
| 0.651 | 0.013 | 0.854 | Aldehyde oxidase inhibitor | 0.186 0.112 DBMET02417 0.799 0.004 DBMET02419 0.854 0.004 DBMET02420 0.541 0.027 DBMET02421 | DBMET02420 | |
| 0.585 | 0.003 | 0.823 | Porphobilinogen synthase inhibitor | 0.823 0.002 DBMET02419 0.79 0.002 DBMET02420 0.594 0.003 DBMET02421 | DBMET02419 | |
| 0.573 | 0.019 | 0.747 | Antithrombotic | 0.747 0.006 DBMET02417 0.416 0.045 DBMET02419 0.427 0.043 DBMET02420 0.248 0.128 DBMET02421 | DBMET02417 | |
| 0.582 | 0.039 | 0.72 | Caspase 9 stimulant | 0.72 0.022 DBMET02417 0.462 0.077 DBMET02419 0.495 0.062 DBMET02420 0.319 0.174 DBMET02421 | DBMET02417 | |
| 0.574 | 0.034 | 0.731 | Transcription factor NF kappa B inhibitor | 0.731 0.017 DBMET02417 0.509 0.043 DBMET02419 0.566 0.036 DBMET02420 0.243 0.133 DBMET02421 | DBMET02417 | |
| 0.558 | 0.02 | 0.558 | Vasodilator, peripheral | 0.435 0.045 DBMET02417 0.43 0.046 DBMET02419 0.448 0.041 DBMET02420 | ||
| 0.533 | 0.005 | 0.533 | Non-steroidal antiinflammatory agent | 0.516 0.006 DBMET02417 0.397 0.014 DBMET02419 0.38 0.016 DBMET02420 0.153 0.111 DBMET02421 | ||
| 0.512 | 0.002 | 0.512 | Keratolytic | 0.468 0.003 DBMET02419 0.495 0.002 DBMET02420 0.162 0.013 DBMET02421 | ||
| 0.521 | 0.021 | 0.578 | GABA C receptor rho-3 antagonist | 0.562 0.013 DBMET02419 0.578 0.01 DBMET02420 0.469 0.035 DBMET02421 | DBMET02420 | |
| 0.491 | 0.003 | 0.593 | Cyclooxygenase 3 inhibitor | 0.593 0.002 DBMET02417 0.246 0.009 DBMET02419 0.247 0.009 DBMET02420 0.152 0.046 DBMET02421 | DBMET02417 | |
| 0.478 | 0.01 | 0.514 | Interleukin agonist | 0.514 0.008 DBMET02417 0.386 0.021 DBMET02419 0.392 0.02 DBMET02420 0.252 0.078 DBMET02421 | DBMET02417 | |
| 0.533 | 0.065 | 0.717 | Apoptosis agonist | 0.717 0.028 DBMET02417 0.45 0.091 DBMET02419 0.514 0.07 DBMET02420 | DBMET02417 | |
| 0.465 | 0.009 | 0.466 | Calcium channel activator | 0.25 0.147 DBMET02417 0.466 0.008 DBMET02419 0.462 0.009 DBMET02420 0.272 0.122 DBMET02421 | DBMET02419 | |
| 0.454 | 0.005 | 0.454 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.322 0.018 DBMET02417 0.423 0.006 DBMET02419 0.446 0.005 DBMET02420 0.253 0.041 DBMET02421 | ||
| 0.45 | 0.011 | 0.463 | Anesthetic general | 0.429 0.013 DBMET02417 0.463 0.01 DBMET02419 0.439 0.012 DBMET02420 0.18 0.086 DBMET02421 | DBMET02419 | |
| 0.49 | 0.053 | 0.889 | Cyclophilin D inhibitor | 0.889 0.005 DBMET02417 0.532 0.042 DBMET02419 0.564 0.034 DBMET02420 | DBMET02417 | |
| 0.435 | 0.004 | 0.563 | Expectorant | 0.563 0.003 DBMET02417 0.31 0.008 DBMET02419 0.318 0.008 DBMET02420 0.168 0.029 DBMET02421 | DBMET02417 | |
| 0.439 | 0.008 | 0.564 | 5 Hydroxytryptamine uptake stimulant | 0.246 0.085 DBMET02417 0.564 0.003 DBMET02419 0.533 0.004 DBMET02420 0.397 0.015 DBMET02421 | DBMET02419 | |
| 0.433 | 0.004 | 0.623 | GABA C receptor agonist | 0.159 0.03 DBMET02417 0.623 0.003 DBMET02419 0.623 0.003 DBMET02420 0.406 0.005 DBMET02421 | DBMET02420 | |
| 0.462 | 0.034 | 0.591 | 5 Hydroxytryptamine release stimulant | 0.591 0.015 DBMET02417 0.422 0.041 DBMET02419 0.378 0.05 DBMET02420 0.192 0.129 DBMET02421 | DBMET02417 | |
| 0.437 | 0.01 | 0.576 | Monophenol monooxygenase inhibitor | 0.576 0.005 DBMET02417 0.444 0.01 DBMET02419 0.526 0.007 DBMET02420 0.159 0.044 DBMET02421 | DBMET02417 | |
| 0.474 | 0.048 | 0.676 | Antibacterial | 0.676 0.011 DBMET02417 0.492 0.043 DBMET02419 0.509 0.038 DBMET02420 0.281 0.15 DBMET02421 | DBMET02417 | |
| 0.429 | 0.003 | 0.584 | Triose-phosphate isomerase inhibitor | 0.584 0.002 DBMET02417 0.443 0.003 DBMET02419 0.385 0.004 DBMET02420 0.181 0.013 DBMET02421 | DBMET02417 | |
| 0.439 | 0.02 | 0.715 | Superoxide dismutase inhibitor | 0.697 0.004 DBMET02419 0.715 0.004 DBMET02420 0.503 0.013 DBMET02421 | DBMET02420 | |
| 0.44 | 0.029 | 0.614 | Apoptosis antagonist | 0.614 0.008 DBMET02417 0.381 0.044 DBMET02419 0.421 0.033 DBMET02420 0.213 0.164 DBMET02421 | DBMET02417 | |
| 0.415 | 0.005 | 0.518 | UDP-glucose 4-epimerase inhibitor | 0.518 0.002 DBMET02417 0.456 0.004 DBMET02419 0.435 0.004 DBMET02420 0.173 0.023 DBMET02421 | DBMET02417 | |
| 0.409 | 0.008 | 0.409 | Lipocortins synthesis antagonist | 0.156 0.097 DBMET02417 0.371 0.011 DBMET02419 0.357 0.013 DBMET02420 0.134 0.132 DBMET02421 | ||
| 0.446 | 0.048 | 0.585 | Immunosuppressant | 0.585 0.015 DBMET02417 0.31 0.109 DBMET02419 0.308 0.11 DBMET02420 | DBMET02417 | |
| 0.426 | 0.028 | 0.585 | Vasodilator, coronary | 0.585 0.008 DBMET02417 0.342 0.059 DBMET02419 0.357 0.052 DBMET02420 | DBMET02417 | |
| 0.454 | 0.058 | 0.504 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.504 0.032 DBMET02419 0.455 0.058 DBMET02420 0.282 0.238 DBMET02421 | DBMET02419 | |
| 0.398 | 0.004 | 0.546 | Succinate dehydrogenase inhibitor | 0.221 0.034 DBMET02417 0.546 0.003 DBMET02419 0.52 0.003 DBMET02420 0.303 0.01 DBMET02421 | DBMET02419 | |
| 0.409 | 0.017 | 0.412 | Transcription factor STAT3 inhibitor | 0.176 0.17 DBMET02417 0.412 0.016 DBMET02419 0.411 0.017 DBMET02420 | DBMET02419 | |
| 0.428 | 0.036 | 0.428 | Caspase 3 stimulant | 0.422 0.038 DBMET02417 0.38 0.05 DBMET02419 0.42 0.039 DBMET02420 | ||
| 0.403 | 0.016 | 0.443 | Sodium/bile acid cotransporter inhibitor | 0.288 0.091 DBMET02417 0.43 0.01 DBMET02419 0.443 0.008 DBMET02420 0.426 0.011 DBMET02421 | DBMET02420 | |
| 0.389 | 0.004 | 0.408 | Ferrochelatase inhibitor | 0.408 0.004 DBMET02419 0.376 0.004 DBMET02420 0.23 0.016 DBMET02421 | DBMET02419 | |
| 0.4 | 0.019 | 0.419 | Transcription factor STAT inhibitor | 0.419 0.015 DBMET02419 0.417 0.016 DBMET02420 | DBMET02419 | |
| 0.39 | 0.009 | 0.483 | Tyrosine 3 hydroxylase inhibitor | 0.183 0.17 DBMET02417 0.441 0.005 DBMET02419 0.483 0.004 DBMET02420 0.443 0.005 DBMET02421 | DBMET02420 | |
| 0.407 | 0.026 | 0.811 | Hypoglycemic | 0.811 0.004 DBMET02417 0.375 0.032 DBMET02419 0.439 0.022 DBMET02420 0.162 0.159 DBMET02421 | DBMET02417 | |
| 0.387 | 0.009 | 0.535 | Protein-tyrosine phosphatase inhibitor | 0.194 0.049 DBMET02417 0.52 0.005 DBMET02419 0.535 0.005 DBMET02420 0.127 0.104 DBMET02421 | DBMET02420 | |
| 0.435 | 0.059 | 0.52 | Calcium channel L-type activator | 0.52 0.021 DBMET02419 0.514 0.023 DBMET02420 0.352 0.116 DBMET02421 | DBMET02419 | |
| 0.403 | 0.028 | 0.739 | Free radical scavenger | 0.739 0.005 DBMET02417 0.499 0.016 DBMET02419 0.594 0.009 DBMET02420 0.208 0.091 DBMET02421 | DBMET02417 | |
| 0.377 | 0.003 | 0.377 | Mucolytic | 0.228 0.009 DBMET02417 0.281 0.005 DBMET02419 0.284 0.005 DBMET02420 0.187 0.017 DBMET02421 | ||
| 0.393 | 0.021 | 0.642 | Peroxidase inhibitor | 0.141 0.083 DBMET02417 0.582 0.005 DBMET02419 0.642 0.004 DBMET02420 0.54 0.007 DBMET02421 | DBMET02420 | |
| 0.407 | 0.036 | 0.421 | Lipoxygenase inhibitor | 0.394 0.039 DBMET02419 0.421 0.033 DBMET02420 | DBMET02420 | |
| 0.377 | 0.006 | 0.377 | Gastrin inhibitor | 0.26 0.067 DBMET02417 0.326 0.018 DBMET02419 0.307 0.028 DBMET02420 0.238 0.093 DBMET02421 | ||
| 0.381 | 0.012 | 0.477 | Interferon gamma antagonist | 0.477 0.007 DBMET02417 0.372 0.012 DBMET02419 0.4 0.011 DBMET02420 0.169 0.058 DBMET02421 | DBMET02417 | |
| 0.38 | 0.024 | 0.511 | DNA synthesis inhibitor | 0.511 0.013 DBMET02417 0.399 0.022 DBMET02419 0.401 0.021 DBMET02420 0.221 0.093 DBMET02421 | DBMET02417 | |
| 0.379 | 0.027 | 0.462 | Vasodilator | 0.462 0.015 DBMET02417 0.261 0.064 DBMET02419 0.31 0.045 DBMET02420 | DBMET02417 | |
| 0.372 | 0.021 | 0.486 | Cyclic AMP phosphodiesterase inhibitor | 0.486 0.008 DBMET02417 0.359 0.024 DBMET02419 0.382 0.019 DBMET02420 | DBMET02417 | |
| 0.363 | 0.012 | 0.386 | DNA methyltransferase I inhibitor | 0.385 0.01 DBMET02417 0.355 0.013 DBMET02419 0.386 0.01 DBMET02420 0.147 0.107 DBMET02421 | DBMET02420 | |
| 0.353 | 0.003 | 0.72 | Glutamate decarboxylase inhibitor | 0.08 0.044 DBMET02417 0.549 0.002 DBMET02419 0.72 0.002 DBMET02420 0.211 0.006 DBMET02421 | DBMET02420 | |
| 0.356 | 0.007 | 0.356 | Phospholipase A2 inhibitor | 0.17 0.059 DBMET02417 0.315 0.011 DBMET02419 0.307 0.012 DBMET02420 0.146 0.078 DBMET02421 | ||
| 0.38 | 0.031 | 0.445 | Platelet antagonist | 0.445 0.02 DBMET02417 0.252 0.072 DBMET02419 0.236 0.079 DBMET02420 | DBMET02417 | |
| 0.351 | 0.004 | 0.418 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.418 0.004 DBMET02417 0.403 0.004 DBMET02419 0.34 0.005 DBMET02420 0.144 0.028 DBMET02421 | DBMET02417 | |
| 0.352 | 0.006 | 0.536 | Interleukin 4 antagonist | 0.194 0.024 DBMET02417 0.451 0.005 DBMET02419 0.536 0.004 DBMET02420 0.116 0.092 DBMET02421 | DBMET02420 | |
| 0.347 | 0.004 | 0.408 | Alcohol dehydrogenase inhibitor | 0.19 0.013 DBMET02417 0.379 0.004 DBMET02419 0.408 0.004 DBMET02420 0.136 0.026 DBMET02421 | DBMET02420 | |
| 0.361 | 0.019 | 0.516 | Dual specificity phosphatase 3 inhibitor | 0.516 0.006 DBMET02419 0.514 0.006 DBMET02420 0.133 0.113 DBMET02421 | DBMET02419 | |
| 0.372 | 0.03 | 0.419 | Hypolipemic | 0.419 0.022 DBMET02417 0.27 0.059 DBMET02419 0.274 0.058 DBMET02420 | DBMET02417 | |
| 0.356 | 0.016 | 0.403 | DNA methylase inhibitor | 0.403 0.011 DBMET02417 0.344 0.018 DBMET02419 0.362 0.015 DBMET02420 0.16 0.109 DBMET02421 | DBMET02417 | |
| 0.342 | 0.004 | 0.431 | Uric acid excretion stimulant | 0.224 0.01 DBMET02417 0.421 0.004 DBMET02419 0.431 0.004 DBMET02420 | DBMET02420 | |
| 0.347 | 0.009 | 0.347 | Insulin sensitizer | 0.243 0.038 DBMET02417 0.298 0.016 DBMET02419 0.3 0.016 DBMET02420 0.222 0.053 DBMET02421 | ||
| 0.349 | 0.012 | 0.452 | Protein kinase stimulant | 0.452 0.005 DBMET02417 0.269 0.022 DBMET02419 0.307 0.016 DBMET02420 0.119 0.093 DBMET02421 | DBMET02417 | |
| 0.376 | 0.04 | 0.802 | Antioxidant | 0.802 0.004 DBMET02417 0.474 0.023 DBMET02419 0.587 0.012 DBMET02420 0.234 0.093 DBMET02421 | DBMET02417 | |
| 0.35 | 0.021 | 0.35 | P-glycoprotein inhibitor | 0.189 0.072 DBMET02417 | ||
| 0.35 | 0.024 | 0.412 | RNA-directed DNA polymerase inhibitor | 0.33 0.027 DBMET02417 0.396 0.019 DBMET02419 0.412 0.017 DBMET02420 0.182 0.13 DBMET02421 | DBMET02420 | |
| 0.331 | 0.006 | 0.448 | Xanthine oxidase inhibitor | 0.32 0.006 DBMET02417 0.371 0.005 DBMET02419 0.448 0.004 DBMET02420 0.088 0.075 DBMET02421 | DBMET02420 | |
| 0.368 | 0.046 | 0.457 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.457 0.026 DBMET02419 0.442 0.029 DBMET02420 | DBMET02419 | |
| 0.343 | 0.021 | 0.525 | Platelet adhesion inhibitor | 0.525 0.005 DBMET02417 0.261 0.046 DBMET02419 0.292 0.037 DBMET02420 | DBMET02417 | |
| 0.334 | 0.023 | 0.486 | Dual specificity phosphatase inhibitor | 0.485 0.007 DBMET02419 0.486 0.007 DBMET02420 0.131 0.118 DBMET02421 | DBMET02420 | |
| 0.323 | 0.013 | 0.386 | Neurotrophic factor enhancer | 0.386 0.006 DBMET02417 0.304 0.017 DBMET02419 0.324 0.013 DBMET02420 0.246 0.041 DBMET02421 | DBMET02417 | |
| 0.318 | 0.008 | 0.354 | Nitric-oxide synthase stimulant | 0.354 0.005 DBMET02417 0.262 0.025 DBMET02419 0.279 0.018 DBMET02420 0.233 0.046 DBMET02421 | DBMET02417 | |
| 0.298 | 0.004 | 0.356 | Electrolyte absorption antagonist | 0.356 0.003 DBMET02419 0.285 0.004 DBMET02420 0.158 0.017 DBMET02421 | DBMET02419 | |
| 0.304 | 0.01 | 0.439 | Protein-tyrosine phosphatase 1B inhibitor | 0.196 0.03 DBMET02417 0.417 0.005 DBMET02419 0.439 0.005 DBMET02420 | DBMET02420 | |
| 0.297 | 0.005 | 0.411 | HIV-1 integrase (Strand Transfer) inhibitor | 0.073 0.034 DBMET02417 0.376 0.004 DBMET02419 0.411 0.004 DBMET02420 0.086 0.028 DBMET02421 | DBMET02420 | |
| 0.313 | 0.02 | 0.538 | Melanin inhibitor | 0.538 0.005 DBMET02417 0.282 0.024 DBMET02419 0.335 0.018 DBMET02420 0.19 0.046 DBMET02421 | DBMET02417 | |
| 0.296 | 0.004 | 0.389 | Macrophage migration inhibitory factor inhibitor | 0.332 0.004 DBMET02419 0.389 0.004 DBMET02420 0.083 0.048 DBMET02421 | DBMET02420 | |
| 0.288 | 0.005 | 0.496 | HIV-1 integrase (3'-Processing) inhibitor | 0.077 0.035 DBMET02417 0.43 0.004 DBMET02419 0.496 0.004 DBMET02420 0.093 0.028 DBMET02421 | DBMET02420 | |
| 0.292 | 0.013 | 0.345 | Aldehyde dehydrogenase inhibitor | 0.327 0.009 DBMET02417 0.333 0.009 DBMET02419 0.345 0.008 DBMET02420 0.176 0.035 DBMET02421 | DBMET02420 | |
| 0.287 | 0.013 | 0.287 | Cholesterol synthesis inhibitor | 0.175 0.034 DBMET02417 0.266 0.015 DBMET02419 0.287 0.013 DBMET02420 0.148 0.046 DBMET02421 | ||
| 0.279 | 0.008 | 0.403 | Mediator release inhibitor | 0.403 0.005 DBMET02417 0.186 0.017 DBMET02419 0.2 0.015 DBMET02420 0.096 0.075 DBMET02421 | DBMET02417 | |
| 0.278 | 0.015 | 0.36 | NADPH oxidase inhibitor | 0.227 0.026 DBMET02417 0.331 0.009 DBMET02419 0.36 0.006 DBMET02420 | DBMET02420 | |
| 0.329 | 0.07 | 0.566 | Immunostimulant | 0.566 0.021 DBMET02417 0.318 0.074 DBMET02419 0.345 0.066 DBMET02420 0.206 0.117 DBMET02421 | DBMET02417 | |
| 0.262 | 0.005 | 0.262 | TRPA1 agonist | 0.141 0.038 DBMET02417 0.219 0.008 DBMET02419 0.238 0.006 DBMET02420 0.124 0.054 DBMET02421 | ||
| 0.273 | 0.018 | 0.358 | Cyclooxygenase 1 inhibitor | 0.107 0.093 DBMET02417 0.251 0.021 DBMET02419 0.269 0.018 DBMET02420 0.358 0.009 DBMET02421 | DBMET02421 | |
| 0.278 | 0.023 | 0.33 | Amyloid beta precursor protein antagonist | 0.313 0.014 DBMET02419 0.33 0.012 DBMET02420 | DBMET02420 | |
| 0.263 | 0.009 | 0.304 | Adenylate kinase inhibitor | 0.228 0.012 DBMET02417 0.304 0.007 DBMET02419 0.285 0.008 DBMET02420 0.201 0.015 DBMET02421 | DBMET02419 | |
| 0.268 | 0.014 | 0.46 | Chelator | 0.409 0.005 DBMET02419 0.46 0.005 DBMET02420 0.368 0.007 DBMET02421 | DBMET02420 | |
| 0.256 | 0.005 | 0.426 | Creatine kinase inhibitor | 0.127 0.036 DBMET02417 0.41 0.003 DBMET02419 0.426 0.003 DBMET02420 0.198 0.011 DBMET02421 | DBMET02420 | |
| 0.252 | 0.003 | 0.285 | Aconitate hydratase inhibitor | 0.062 0.024 DBMET02417 0.285 0.002 DBMET02419 0.224 0.003 DBMET02420 0.122 0.005 DBMET02421 | DBMET02419 | |
| 0.261 | 0.011 | 0.497 | Carbonic anhydrase XV inhibitor | 0.447 0.004 DBMET02419 0.497 0.003 DBMET02420 0.118 0.049 DBMET02421 | DBMET02420 | |
| 0.31 | 0.066 | 0.441 | Spasmolytic | 0.441 0.032 DBMET02417 0.301 0.07 DBMET02419 0.314 0.065 DBMET02420 | DBMET02417 | |
| 0.304 | 0.064 | 0.404 | Hypoxia-inducible factor 1 alpha inhibitor | 0.404 0.029 DBMET02417 0.346 0.046 DBMET02419 0.372 0.038 DBMET02420 0.217 0.133 DBMET02421 | DBMET02417 | |
| 0.265 | 0.024 | 0.463 | Lipid peroxidase inhibitor | 0.463 0.007 DBMET02417 0.268 0.024 DBMET02419 0.343 0.014 DBMET02420 0.127 0.087 DBMET02421 | DBMET02417 | |
| 0.246 | 0.006 | 0.246 | Arachidonic acid antagonist | 0.197 0.035 DBMET02417 0.236 0.009 DBMET02419 0.233 0.01 DBMET02420 0.199 0.034 DBMET02421 | ||
| 0.253 | 0.015 | 0.611 | Cystathionine beta-synthase inhibitor | 0.406 0.005 DBMET02417 0.505 0.004 DBMET02419 0.611 0.003 DBMET02420 0.315 0.009 DBMET02421 | DBMET02420 | |
| 0.256 | 0.019 | 0.256 | Anesthetic local | 0.206 0.031 DBMET02419 0.179 0.038 DBMET02420 | ||
| 0.245 | 0.009 | 0.52 | Histidine decarboxylase inhibitor | 0.063 0.058 DBMET02417 0.475 0.003 DBMET02419 0.52 0.003 DBMET02420 0.389 0.004 DBMET02421 | DBMET02420 | |
| 0.241 | 0.005 | 0.331 | HIV-1 integrase (Overall Integration) inhibitor | 0.331 0.003 DBMET02419 0.301 0.004 DBMET02420 0.22 0.008 DBMET02421 | DBMET02419 | |
| 0.237 | 0.004 | 0.237 | Sphingosine 1-phosphate receptor 5 antagonist | 0.213 0.007 DBMET02419 0.206 0.009 DBMET02420 0.133 0.093 DBMET02421 | ||
| 0.244 | 0.013 | 0.244 | Antibacterial (Helicobacter pylori) | 0.178 0.029 DBMET02419 0.181 0.028 DBMET02420 | ||
| 0.257 | 0.026 | 0.729 | Amylase inhibitor | 0.729 0.003 DBMET02417 0.347 0.013 DBMET02419 0.395 0.009 DBMET02420 0.236 0.032 DBMET02421 | DBMET02417 | |
| 0.25 | 0.019 | 0.456 | Insulin secretagoues | 0.456 0.005 DBMET02417 0.23 0.024 DBMET02419 0.254 0.019 DBMET02420 | DBMET02417 | |
| 0.234 | 0.008 | 0.323 | Photosensitizer | 0.323 0.004 DBMET02417 0.207 0.011 DBMET02419 0.211 0.011 DBMET02420 0.156 0.028 DBMET02421 | DBMET02417 | |
| 0.257 | 0.033 | 0.529 | Mcl-1 antagonist | 0.503 0.005 DBMET02419 0.529 0.005 DBMET02420 0.227 0.044 DBMET02421 | DBMET02420 | |
| 0.269 | 0.047 | 0.59 | Nitric oxide antagonist | 0.59 0.01 DBMET02417 0.247 0.052 DBMET02419 0.313 0.038 DBMET02420 | DBMET02417 | |
| 0.223 | 0.009 | 0.387 | Phosphofructokinase-1 inhibitor | 0.387 0.003 DBMET02417 0.337 0.004 DBMET02419 0.329 0.004 DBMET02420 0.155 0.017 DBMET02421 | DBMET02417 | |
| 0.216 | 0.003 | 0.216 | Ca2+-transporting ATPase inhibitor | 0.195 0.004 DBMET02417 0.209 0.003 DBMET02419 0.2 0.004 DBMET02420 0.156 0.031 DBMET02421 | ||
| 0.217 | 0.005 | 0.273 | Biliverdin reductase inhibitor | 0.135 0.011 DBMET02417 0.273 0.004 DBMET02419 0.246 0.004 DBMET02420 0.11 0.016 DBMET02421 | DBMET02419 | |
| 0.229 | 0.017 | 0.253 | GABA C receptor rho-2 antagonist | 0.247 0.012 DBMET02419 0.253 0.011 DBMET02420 0.172 0.049 DBMET02421 | DBMET02420 | |
| 0.215 | 0.004 | 0.215 | Elastase 1 inhibitor | 0.089 0.028 DBMET02419 0.083 0.033 DBMET02420 | ||
| 0.217 | 0.006 | 0.241 | GABA C receptor rho-1 antagonist | 0.236 0.005 DBMET02419 0.241 0.005 DBMET02420 0.129 0.033 DBMET02421 | DBMET02420 | |
| 0.231 | 0.02 | 0.424 | Cell wall synthesis inhibitor | 0.424 0.005 DBMET02417 0.246 0.017 DBMET02419 0.256 0.015 DBMET02420 0.138 0.077 DBMET02421 | DBMET02417 | |
| 0.22 | 0.009 | 0.526 | NADH dehydrogenase inhibitor | 0.526 0.003 DBMET02417 0.367 0.005 DBMET02419 0.341 0.006 DBMET02420 0.209 0.01 DBMET02421 | DBMET02417 | |
| 0.214 | 0.004 | 0.214 | Glycine receptor agonist | 0.148 0.007 DBMET02417 0.187 0.004 DBMET02419 0.17 0.005 DBMET02420 0.109 0.016 DBMET02421 | ||
| 0.222 | 0.015 | 0.235 | Microtubule formation inhibitor | 0.235 0.013 DBMET02417 0.163 0.031 DBMET02419 0.16 0.033 DBMET02420 | DBMET02417 | |
| 0.222 | 0.015 | 0.222 | Toll-Like receptor 2 antagonist | 0.117 0.081 DBMET02417 0.195 0.026 DBMET02419 0.213 0.018 DBMET02420 0.153 0.05 DBMET02421 | ||
| 0.213 | 0.008 | 0.213 | ABCA1 expression enhancer | 0.137 0.022 DBMET02419 0.138 0.021 DBMET02420 | ||
| 0.278 | 0.073 | 0.361 | Insulysin inhibitor | 0.361 0.03 DBMET02419 0.36 0.031 DBMET02420 0.325 0.045 DBMET02421 | DBMET02419 | |
| 0.216 | 0.012 | 0.316 | Potassium channel (Ca-activated) activator | 0.316 0.005 DBMET02419 0.269 0.006 DBMET02420 0.125 0.038 DBMET02421 | DBMET02419 | |
| 0.215 | 0.013 | 0.215 | Catalase inhibitor | 0.201 0.015 DBMET02419 0.208 0.014 DBMET02420 0.112 0.035 DBMET02421 | ||
| 0.224 | 0.022 | 0.252 | Adenylate cyclase inhibitor | 0.142 0.051 DBMET02417 0.252 0.019 DBMET02419 0.248 0.019 DBMET02420 0.141 0.051 DBMET02421 | DBMET02419 | |
| 0.21 | 0.009 | 0.302 | Glutamate dehydrogenase inhibitor | 0.149 0.016 DBMET02417 0.302 0.005 DBMET02419 0.258 0.007 DBMET02420 0.169 0.013 DBMET02421 | DBMET02419 | |
| 0.244 | 0.045 | 0.646 | Hepatoprotectant | 0.646 0.004 DBMET02417 0.232 0.049 DBMET02419 0.277 0.036 DBMET02420 0.148 0.112 DBMET02421 | DBMET02417 | |
| 0.21 | 0.011 | 0.257 | GABA C receptor antagonist | 0.257 0.006 DBMET02419 0.257 0.006 DBMET02420 0.144 0.033 DBMET02421 | DBMET02420 | |
| 0.218 | 0.021 | 0.382 | Catenin beta inhibitor | 0.376 0.004 DBMET02419 0.382 0.004 DBMET02420 0.167 0.071 DBMET02421 | DBMET02420 | |
| 0.209 | 0.013 | 0.286 | Carbonic anhydrase XIII inhibitor | 0.232 0.01 DBMET02417 0.246 0.009 DBMET02419 0.286 0.006 DBMET02420 0.085 0.046 DBMET02421 | DBMET02420 | |
| 0.231 | 0.036 | 0.234 | 3C-like protease (Human coronavirus) inhibitor | 0.234 0.035 DBMET02419 0.22 0.041 DBMET02420 | DBMET02419 | |
| 0.2 | 0.007 | 0.428 | Phenylalanine 4-hydroxylase inhibitor | 0.073 0.043 DBMET02417 0.393 0.003 DBMET02419 0.428 0.003 DBMET02420 0.317 0.004 DBMET02421 | DBMET02420 | |
| 0.259 | 0.066 | 0.872 | Angiogenesis stimulant | 0.872 0.003 DBMET02417 0.311 0.045 DBMET02419 0.349 0.033 DBMET02420 0.196 0.097 DBMET02421 | DBMET02417 | |
| 0.265 | 0.073 | 0.265 | Aryl hydrocarbon receptor agonist | 0.252 0.078 DBMET02419 0.253 0.077 DBMET02420 | ||
| 0.259 | 0.067 | 0.401 | Antiamyloidogenic | 0.374 0.034 DBMET02417 0.348 0.039 DBMET02419 0.401 0.028 DBMET02420 | DBMET02420 | |
| 0.224 | 0.033 | 0.224 | Cyclooxygenase inhibitor | 0.182 0.049 DBMET02419 0.187 0.047 DBMET02420 0.188 0.047 DBMET02421 | ||
| 0.2 | 0.009 | 0.2 | Prolactin inhibitor | 0.151 0.022 DBMET02419 0.173 0.014 DBMET02420 0.104 0.051 DBMET02421 | ||
| 0.208 | 0.017 | 0.226 | CF transmembrane conductance regulator agonist | 0.205 0.019 DBMET02417 0.213 0.015 DBMET02419 0.226 0.011 DBMET02420 0.137 0.102 DBMET02421 | DBMET02420 | |
| 0.2 | 0.009 | 0.284 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.261 0.005 DBMET02419 0.284 0.005 DBMET02420 0.117 0.03 DBMET02421 | DBMET02420 | |
| 0.28 | 0.091 | 0.422 | 12-Lipoxygenase inhibitor | 0.394 0.041 DBMET02419 0.422 0.034 DBMET02420 | DBMET02420 | |
| 0.207 | 0.02 | 0.287 | Farnesoid X receptor antagonist | 0.238 0.013 DBMET02419 0.287 0.007 DBMET02420 0.143 0.061 DBMET02421 | DBMET02420 | |
| 0.196 | 0.009 | 0.196 | Sphingosine 1-phosphate receptor 2 antagonist | 0.178 0.016 DBMET02419 0.178 0.016 DBMET02420 0.116 0.108 DBMET02421 | ||
| 0.189 | 0.002 | 0.371 | Adenine nucleotide translocase inhibitor | 0.095 0.005 DBMET02417 0.371 0.002 DBMET02419 0.356 0.002 DBMET02420 0.063 0.023 DBMET02421 | DBMET02419 | |
| 0.226 | 0.041 | 0.442 | Thrombolytic | 0.442 0.008 DBMET02417 0.23 0.039 DBMET02419 0.237 0.037 DBMET02420 0.139 0.091 DBMET02421 | DBMET02417 | |
| 0.193 | 0.008 | 0.347 | DOPA decarboxylase inhibitor | 0.107 0.063 DBMET02417 0.304 0.003 DBMET02419 0.347 0.002 DBMET02420 0.19 0.008 DBMET02421 | DBMET02420 | |
| 0.207 | 0.023 | 0.27 | 5-Lipoxygenase inhibitor | 0.244 0.017 DBMET02419 0.27 0.013 DBMET02420 | DBMET02420 | |
| 0.218 | 0.034 | 0.452 | Phospholipase C inhibitor | 0.282 0.02 DBMET02417 0.418 0.009 DBMET02419 0.452 0.008 DBMET02420 0.236 0.028 DBMET02421 | DBMET02420 | |
| 0.189 | 0.008 | 0.219 | Argininosuccinate synthase inhibitor | 0.128 0.014 DBMET02417 0.219 0.007 DBMET02419 0.192 0.008 DBMET02420 0.084 0.024 DBMET02421 | DBMET02419 | |
| 0.306 | 0.128 | 0.443 | 15-Lipoxygenase inhibitor | 0.408 0.071 DBMET02419 0.443 0.056 DBMET02420 | DBMET02420 | |
| 0.215 | 0.039 | 0.362 | Diuretic | 0.362 0.015 DBMET02417 0.248 0.031 DBMET02419 0.228 0.035 DBMET02420 | DBMET02417 | |
| 0.187 | 0.012 | 0.194 | Caspase 3 inhibitor | 0.194 0.01 DBMET02419 0.179 0.014 DBMET02420 0.126 0.051 DBMET02421 | DBMET02419 | |
| 0.182 | 0.011 | 0.265 | Heat shock protein 70 antagonist | 0.217 0.005 DBMET02417 0.26 0.004 DBMET02419 0.265 0.004 DBMET02420 0.146 0.054 DBMET02421 | DBMET02420 | |
| 0.194 | 0.023 | 0.223 | Aminopeptidase B inhibitor | 0.223 0.017 DBMET02419 0.211 0.019 DBMET02420 0.184 0.025 DBMET02421 | DBMET02419 | |
| 0.19 | 0.019 | 0.208 | Adenylate cyclase stimulant | 0.179 0.027 DBMET02417 0.196 0.015 DBMET02419 0.208 0.01 DBMET02420 0.179 0.027 DBMET02421 | DBMET02420 | |
| 0.189 | 0.018 | 0.402 | Carbonic anhydrase III inhibitor | 0.203 0.016 DBMET02417 0.346 0.004 DBMET02419 0.402 0.004 DBMET02420 0.162 0.024 DBMET02421 | DBMET02420 | |
| 0.173 | 0.005 | 0.312 | Xanthine dehydrogenase inhibitor | 0.06 0.039 DBMET02417 0.282 0.003 DBMET02419 0.312 0.003 DBMET02420 0.062 0.037 DBMET02421 | DBMET02420 | |
| 0.231 | 0.066 | 0.302 | Psychostimulant | 0.302 0.042 DBMET02417 0.146 0.12 DBMET02419 0.151 0.115 DBMET02420 | DBMET02417 | |
| 0.198 | 0.033 | 0.494 | Hemostatic | 0.494 0.004 DBMET02417 0.161 0.056 DBMET02419 0.171 0.048 DBMET02420 | DBMET02417 | |
| 0.199 | 0.036 | 0.432 | Hexokinase inhibitor | 0.432 0.004 DBMET02417 0.311 0.01 DBMET02419 0.314 0.009 DBMET02420 | DBMET02417 | |
| 0.215 | 0.053 | 0.29 | Growth hormone agonist | 0.185 0.065 DBMET02419 0.159 0.08 DBMET02420 0.29 0.034 DBMET02421 | DBMET02421 | |
| 0.168 | 0.007 | 0.179 | Ornithine decarboxylase inhibitor | 0.111 0.033 DBMET02417 0.179 0.006 DBMET02419 0.178 0.006 DBMET02420 0.112 0.032 DBMET02421 | DBMET02419 | |
| 0.166 | 0.008 | 0.166 | Leukotriene antagonist | 0.077 0.034 DBMET02417 0.164 0.009 DBMET02419 0.157 0.009 DBMET02420 0.084 0.029 DBMET02421 | ||
| 0.161 | 0.004 | 0.161 | Estrogen-related receptor beta agonist | 0.136 0.005 DBMET02419 0.143 0.005 DBMET02420 0.118 0.011 DBMET02421 | ||
| 0.173 | 0.016 | 0.479 | AMP-activated protein kinase stimulant | 0.479 0.003 DBMET02417 0.236 0.007 DBMET02419 0.262 0.006 DBMET02420 | DBMET02417 | |
| 0.166 | 0.011 | 0.174 | Anabolic | 0.116 0.044 DBMET02417 0.167 0.011 DBMET02419 0.174 0.009 DBMET02420 0.122 0.038 DBMET02421 | DBMET02420 | |
| 0.172 | 0.017 | 0.282 | Carbonic anhydrase VI inhibitor | 0.121 0.029 DBMET02417 0.229 0.01 DBMET02419 0.282 0.007 DBMET02420 0.105 0.036 DBMET02421 | DBMET02420 | |
| 0.164 | 0.009 | 0.293 | Potassium channel large-conductance Ca-activated activator | 0.293 0.004 DBMET02419 0.24 0.005 DBMET02420 0.122 0.016 DBMET02421 | DBMET02419 | |
| 0.172 | 0.018 | 0.172 | Cathepsin G inhibitor | 0.106 0.031 DBMET02419 0.092 0.037 DBMET02420 | ||
| 0.195 | 0.041 | 0.407 | ATPase inhibitor | 0.407 0.004 DBMET02417 0.212 0.028 DBMET02419 0.218 0.025 DBMET02420 0.15 0.101 DBMET02421 | DBMET02417 | |
| 0.189 | 0.036 | 0.397 | Topoisomerase II inhibitor | 0.397 0.01 DBMET02417 0.268 0.022 DBMET02419 0.332 0.015 DBMET02420 | DBMET02417 | |
| 0.157 | 0.007 | 0.157 | NMDA receptor agonist | 0.148 0.008 DBMET02419 0.127 0.012 DBMET02420 0.076 0.031 DBMET02421 | ||
| 0.156 | 0.006 | 0.237 | Purinergic P2X1 antagonist | 0.107 0.014 DBMET02417 0.237 0.002 DBMET02419 0.22 0.003 DBMET02420 0.131 0.009 DBMET02421 | DBMET02419 | |
| 0.156 | 0.009 | 0.185 | Acyl-CoA dehydrogenase inhibitor | 0.091 0.018 DBMET02417 0.185 0.006 DBMET02419 0.174 0.007 DBMET02420 0.087 0.02 DBMET02421 | DBMET02419 | |
| 0.185 | 0.039 | 0.304 | Mannose-6-phosphate isomerase inhibitor | 0.304 0.005 DBMET02417 0.301 0.005 DBMET02419 0.276 0.008 DBMET02420 0.202 0.029 DBMET02421 | DBMET02417 | |
| 0.149 | 0.004 | 0.184 | Nicotinic acid receptor agonist | 0.184 0.004 DBMET02419 0.184 0.004 DBMET02420 | DBMET02420 | |
| 0.155 | 0.011 | 0.155 | Glutathione S-transferase inhibitor | 0.078 0.064 DBMET02417 0.137 0.015 DBMET02419 0.132 0.017 DBMET02420 0.108 0.03 DBMET02421 | ||
| 0.157 | 0.015 | 0.179 | Thioredoxin inhibitor | 0.179 0.011 DBMET02417 0.086 0.069 DBMET02419 0.101 0.047 DBMET02420 | DBMET02417 | |
| 0.147 | 0.006 | 0.224 | Neuraminidase inhibitor | 0.136 0.008 DBMET02417 0.201 0.004 DBMET02419 0.224 0.004 DBMET02420 | DBMET02420 | |
| 0.148 | 0.008 | 0.272 | GABA aminotransferase inhibitor | 0.174 0.005 DBMET02417 0.251 0.004 DBMET02419 0.272 0.004 DBMET02420 0.104 0.024 DBMET02421 | DBMET02420 | |
| 0.143 | 0.008 | 0.226 | Neuraminidase (influenza) inhibitor | 0.168 0.006 DBMET02417 0.206 0.005 DBMET02419 0.226 0.004 DBMET02420 | DBMET02420 | |
| 0.149 | 0.015 | 0.164 | Carbonic anhydrase V inhibitor | 0.148 0.015 DBMET02419 0.164 0.012 DBMET02420 0.063 0.049 DBMET02421 | DBMET02420 | |
| 0.143 | 0.01 | 0.143 | Leukotriene synthesis inhibitor | 0.135 0.012 DBMET02419 0.14 0.011 DBMET02420 | ||
| 0.136 | 0.005 | 0.136 | NMDA receptor glycine site agonist | 0.124 0.008 DBMET02419 0.107 0.013 DBMET02420 0.074 0.033 DBMET02421 | ||
| 0.144 | 0.014 | 0.144 | Peroxisome proliferator-activated receptor gamma agonist | 0.121 0.02 DBMET02419 0.13 0.018 DBMET02420 0.077 0.043 DBMET02421 | ||
| 0.137 | 0.009 | 0.286 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.146 0.008 DBMET02417 0.247 0.003 DBMET02419 0.286 0.003 DBMET02420 0.062 0.037 DBMET02421 | DBMET02420 | |
| 0.138 | 0.01 | 0.206 | HIV-1 integrase inhibitor | 0.199 0.005 DBMET02419 0.206 0.005 DBMET02420 0.122 0.015 DBMET02421 | DBMET02420 | |
| 0.139 | 0.014 | 0.163 | Aminopeptidase I inhibitor | 0.163 0.01 DBMET02419 0.153 0.012 DBMET02420 0.137 0.015 DBMET02421 | DBMET02419 | |
| 0.128 | 0.005 | 0.141 | Glutamate (mGluR6) antagonist | 0.08 0.025 DBMET02417 0.141 0.004 DBMET02419 0.124 0.005 DBMET02420 0.074 0.032 DBMET02421 | DBMET02419 | |
| 0.13 | 0.008 | 0.181 | Maillard reaction inhibitor | 0.181 0.004 DBMET02419 0.18 0.004 DBMET02420 0.079 0.025 DBMET02421 | DBMET02419 | |
| 0.131 | 0.01 | 0.152 | Granulocyte macrophage colony stimulating factor agonist | 0.152 0.005 DBMET02419 0.134 0.009 DBMET02420 0.106 0.028 DBMET02421 | DBMET02419 | |
| 0.133 | 0.012 | 0.163 | Bile acid receptor antagonist | 0.096 0.058 DBMET02417 0.152 0.007 DBMET02419 0.163 0.006 DBMET02420 0.117 0.023 DBMET02421 | DBMET02420 | |
| 0.134 | 0.014 | 0.148 | Carbonic anhydrase VA inhibitor | 0.133 0.015 DBMET02419 0.148 0.011 DBMET02420 0.07 0.046 DBMET02421 | DBMET02420 | |
| 0.175 | 0.055 | 0.215 | Neurotensin receptor agonist | 0.206 0.032 DBMET02419 0.215 0.029 DBMET02420 0.173 0.058 DBMET02421 | DBMET02420 | |
| 0.2 | 0.081 | 0.366 | Pyruvate kinase inhibitor | 0.361 0.03 DBMET02419 0.366 0.029 DBMET02420 0.182 0.092 DBMET02421 | DBMET02420 | |
| 0.126 | 0.006 | 0.171 | Topoisomerase II beta inhibitor | 0.093 0.01 DBMET02417 0.147 0.005 DBMET02419 0.171 0.004 DBMET02420 | DBMET02420 | |
| 0.125 | 0.006 | 0.206 | GABA B receptor agonist | 0.177 0.004 DBMET02419 0.206 0.003 DBMET02420 0.101 0.016 DBMET02421 | DBMET02420 | |
| 0.127 | 0.009 | 0.127 | Peroxisome proliferator-activated receptor gamma antagonist | 0.102 0.014 DBMET02419 0.099 0.016 DBMET02420 0.069 0.055 DBMET02421 | ||
| 0.183 | 0.065 | 0.183 | Tumour necrosis factor antagonist | 0.157 0.092 DBMET02419 0.164 0.083 DBMET02420 | ||
| 0.166 | 0.048 | 0.232 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.232 0.008 DBMET02419 0.231 0.009 DBMET02420 | DBMET02419 | |
| 0.122 | 0.004 | 0.122 | Retinoid X alpha receptor agonist | 0.113 0.004 DBMET02419 0.096 0.005 DBMET02420 0.037 0.022 DBMET02421 | ||
| 0.123 | 0.008 | 0.123 | Leukocyte elastase inhibitor | 0.048 0.025 DBMET02419 0.045 0.028 DBMET02420 | ||
| 0.12 | 0.005 | 0.187 | Nicotinic acid receptor 2 agonist | 0.175 0.004 DBMET02419 0.187 0.004 DBMET02420 | DBMET02420 | |
| 0.126 | 0.011 | 0.228 | D-Ala-D-Ala ligase inhibitor | 0.228 0.003 DBMET02419 0.202 0.003 DBMET02420 0.138 0.007 DBMET02421 | DBMET02419 | |
| 0.131 | 0.016 | 0.201 | Glutamate release inhibitor | 0.201 0.005 DBMET02417 0.172 0.006 DBMET02419 0.149 0.01 DBMET02420 0.095 0.051 DBMET02421 | DBMET02417 | |
| 0.149 | 0.034 | 0.163 | Sphingosine 1-phosphate receptor 4 antagonist | 0.163 0.023 DBMET02419 0.154 0.03 DBMET02420 | DBMET02419 | |
| 0.14 | 0.026 | 0.14 | Calcium antagonist | 0.079 0.065 DBMET02419 | ||
| 0.242 | 0.128 | 0.517 | Interleukin 2 agonist | 0.517 0.006 DBMET02417 0.355 0.043 DBMET02419 0.376 0.035 DBMET02420 0.304 0.071 DBMET02421 | DBMET02417 | |
| 0.12 | 0.007 | 0.203 | Carbonic anhydrase XIV inhibitor | 0.146 0.005 DBMET02417 0.145 0.005 DBMET02419 0.203 0.004 DBMET02420 0.046 0.038 DBMET02421 | DBMET02420 | |
| 0.116 | 0.005 | 0.174 | Urate transporter 1 inhibitor | 0.174 0.004 DBMET02419 0.152 0.004 DBMET02420 | DBMET02419 | |
| 0.197 | 0.086 | 0.259 | Interleukin antagonist | 0.207 0.08 DBMET02419 0.259 0.058 DBMET02420 | DBMET02420 | |
| 0.139 | 0.028 | 0.208 | Toll-Like receptor 4 antagonist | 0.208 0.005 DBMET02417 0.126 0.038 DBMET02419 0.137 0.029 DBMET02420 | DBMET02417 | |
| 0.121 | 0.011 | 0.121 | Prostaglandin E2 antagonist | 0.102 0.014 DBMET02419 0.081 0.019 DBMET02420 | ||
| 0.117 | 0.008 | 0.245 | Plasminogen activator inhibitor antagonist | 0.245 0.004 DBMET02419 0.233 0.004 DBMET02420 | DBMET02419 | |
| 0.133 | 0.026 | 0.138 | Interleukin 1 beta converting enzyme inhibitor | 0.138 0.023 DBMET02419 0.131 0.027 DBMET02420 0.107 0.049 DBMET02421 | DBMET02419 | |
| 0.115 | 0.008 | 0.141 | Leukotriene B4 antagonist | 0.108 0.009 DBMET02417 0.141 0.005 DBMET02419 0.133 0.006 DBMET02420 0.072 0.019 DBMET02421 | DBMET02419 | |
| 0.11 | 0.005 | 0.11 | Nitric oxide donor | 0.089 0.015 DBMET02417 0.078 0.024 DBMET02419 0.077 0.024 DBMET02420 | ||
| 0.147 | 0.042 | 0.147 | Interleukin 1b antagonist | |||
| 0.11 | 0.006 | 0.12 | Glutamate (mGluR7) antagonist | 0.12 0.005 DBMET02419 0.111 0.006 DBMET02420 0.077 0.032 DBMET02421 | DBMET02419 | |
| 0.15 | 0.046 | 0.173 | Cathepsin H inhibitor | 0.173 0.032 DBMET02419 0.152 0.045 DBMET02420 | DBMET02419 | |
| 0.154 | 0.051 | 0.154 | Cyclooxygenase 2 inhibitor | 0.128 0.072 DBMET02419 0.129 0.071 DBMET02420 0.128 0.072 DBMET02421 | ||
| 0.146 | 0.043 | 0.17 | Vanilloid 1 agonist | 0.17 0.023 DBMET02417 0.151 0.037 DBMET02419 0.156 0.033 DBMET02420 0.145 0.044 DBMET02421 | DBMET02417 | |
| 0.106 | 0.004 | 0.106 | Ryanodine receptor antagonist | 0.101 0.004 DBMET02419 0.103 0.004 DBMET02420 0.065 0.025 DBMET02421 | ||
| 0.14 | 0.04 | 0.172 | CC chemokine 6 receptor antagonist | 0.172 0.007 DBMET02417 0.164 0.01 DBMET02419 0.154 0.018 DBMET02420 | DBMET02417 | |
| 0.19 | 0.09 | 0.19 | Antimitotic | |||
| 0.148 | 0.048 | 0.356 | Alkylator | 0.356 0.009 DBMET02417 0.128 0.061 DBMET02419 0.141 0.052 DBMET02420 | DBMET02417 | |
| 0.116 | 0.019 | 0.146 | Interferon agonist | 0.146 0.011 DBMET02417 0.093 0.035 DBMET02419 0.081 0.051 DBMET02420 | DBMET02417 | |
| 0.101 | 0.005 | 0.101 | Retinoid X receptor agonist | 0.096 0.005 DBMET02419 0.084 0.007 DBMET02420 | ||
| 0.111 | 0.016 | 0.115 | Prostaglandin EP2 antagonist | 0.077 0.028 DBMET02417 0.115 0.015 DBMET02419 0.105 0.018 DBMET02420 | DBMET02419 | |
| 0.1 | 0.005 | 0.1 | Factor III inhibitor | 0.069 0.011 DBMET02417 0.089 0.005 DBMET02419 0.096 0.005 DBMET02420 | ||
| 0.097 | 0.004 | 0.097 | Pregnane X receptor antagonist | 0.085 0.005 DBMET02419 0.082 0.006 DBMET02420 | ||
| 0.093 | 0.002 | 0.093 | Elastase 3B inhibitor | 0.039 0.009 DBMET02419 0.034 0.015 DBMET02420 | ||
| 0.093 | 0.002 | 0.093 | Elastase 3A inhibitor | 0.039 0.009 DBMET02419 0.034 0.015 DBMET02420 | ||
| 0.093 | 0.002 | 0.093 | Elastase 2B inhibitor | 0.039 0.009 DBMET02419 0.034 0.015 DBMET02420 | ||
| 0.099 | 0.01 | 0.099 | Exportin-1 inhibitor | 0.068 0.047 DBMET02419 0.07 0.042 DBMET02420 | ||
| 0.091 | 0.003 | 0.156 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.156 0.002 DBMET02419 0.154 0.002 DBMET02420 0.048 0.018 DBMET02421 | DBMET02419 | |
| 0.149 | 0.061 | 0.244 | Alkaline phosphatase inhibitor | 0.222 0.026 DBMET02417 0.221 0.027 DBMET02419 0.244 0.021 DBMET02420 | DBMET02420 | |
| 0.092 | 0.005 | 0.105 | Dopamine D5 agonist | 0.088 0.005 DBMET02419 0.105 0.004 DBMET02420 0.05 0.017 DBMET02421 | DBMET02420 | |
| 0.093 | 0.006 | 0.118 | Fumarate hydratase inhibitor | 0.068 0.009 DBMET02417 0.118 0.005 DBMET02419 0.108 0.005 DBMET02420 0.048 0.014 DBMET02421 | DBMET02419 | |
| 0.147 | 0.06 | 0.147 | Interleukin 1 antagonist | |||
| 0.145 | 0.059 | 0.255 | M17 leucyl aminopeptidase inhibitor | 0.255 0.019 DBMET02419 0.251 0.02 DBMET02420 | DBMET02419 | |
| 0.141 | 0.055 | 0.271 | DNA polymerase I inhibitor | 0.2 0.028 DBMET02417 0.237 0.019 DBMET02419 0.271 0.014 DBMET02420 0.117 0.07 DBMET02421 | DBMET02420 | |
| 0.098 | 0.013 | 0.098 | Peroxisome proliferator-activated receptor alpha agonist | 0.08 0.017 DBMET02419 0.079 0.018 DBMET02420 | ||
| 0.152 | 0.067 | 0.177 | Thiol protease inhibitor | 0.177 0.05 DBMET02419 0.154 0.065 DBMET02420 | DBMET02419 | |
| 0.09 | 0.006 | 0.091 | Lysophosphatidic acid 3 receptor antagonist | 0.091 0.006 DBMET02419 0.085 0.008 DBMET02420 | DBMET02419 | |
| 0.087 | 0.003 | 0.105 | Glutamate (mGluR3) agonist | 0.032 0.022 DBMET02417 0.095 0.002 DBMET02419 0.105 0.002 DBMET02420 0.039 0.01 DBMET02421 | DBMET02420 | |
| 0.105 | 0.022 | 0.105 | Calcium channel L-type blocker | 0.069 0.054 DBMET02419 | ||
| 0.1 | 0.017 | 0.1 | Prostaglandin antagonist | 0.069 0.027 DBMET02419 0.053 0.037 DBMET02420 | ||
| 0.095 | 0.013 | 0.095 | Thromboxane antagonist | 0.089 0.015 DBMET02419 0.08 0.02 DBMET02420 | ||
| 0.09 | 0.01 | 0.397 | CD45 antagonist | 0.397 0.003 DBMET02419 0.275 0.004 DBMET02420 0.07 0.015 DBMET02421 | DBMET02419 | |
| 0.094 | 0.015 | 0.113 | Interferon inducer | 0.113 0.009 DBMET02417 0.075 0.029 DBMET02419 0.065 0.043 DBMET02420 | DBMET02417 | |
| 0.12 | 0.042 | 0.12 | Gastric antisecretory | 0.101 0.065 DBMET02419 0.098 0.068 DBMET02420 | ||
| 0.08 | 0.005 | 0.1 | GABA uptake inhibitor | 0.1 0.004 DBMET02419 0.077 0.005 DBMET02420 | DBMET02419 | |
| 0.086 | 0.011 | 0.086 | 5-Alpha-reductase inhibitor | 0.067 0.014 DBMET02419 0.066 0.014 DBMET02420 | ||
| 0.093 | 0.019 | 0.096 | CDC25B inhibitor | 0.095 0.018 DBMET02419 0.096 0.017 DBMET02420 | DBMET02420 | |
| 0.12 | 0.046 | 0.592 | Beta glucuronidase inhibitor | 0.592 0.003 DBMET02417 0.174 0.017 DBMET02419 0.196 0.013 DBMET02420 | DBMET02417 | |
| 0.08 | 0.007 | 0.282 | Heparanase inhibitor | 0.282 0.002 DBMET02417 0.083 0.005 DBMET02419 0.078 0.008 DBMET02420 0.06 0.023 DBMET02421 | DBMET02417 | |
| 0.077 | 0.005 | 0.103 | Retinoic acid alpha receptor agonist | 0.103 0.004 DBMET02419 0.092 0.004 DBMET02420 | DBMET02419 | |
| 0.078 | 0.005 | 0.078 | Peroxisome proliferator-activated receptor alpha antagonist | 0.042 0.009 DBMET02419 0.035 0.01 DBMET02420 | ||
| 0.076 | 0.004 | 0.106 | Retinoic acid receptor agonist | 0.106 0.004 DBMET02419 0.097 0.004 DBMET02420 | DBMET02419 | |
| 0.085 | 0.014 | 0.085 | Sphingosine 1-phosphate receptor 3 antagonist | 0.076 0.02 DBMET02419 0.074 0.021 DBMET02420 | ||
| 0.081 | 0.01 | 0.136 | Glucose-6-phosphate translocase inhibitor | 0.136 0.004 DBMET02417 0.077 0.013 DBMET02419 0.09 0.008 DBMET02420 | DBMET02417 | |
| 0.088 | 0.017 | 0.088 | Transcription factor AP-1 inhibitor | 0.068 0.032 DBMET02417 0.06 0.045 DBMET02419 0.066 0.035 DBMET02420 | ||
| 0.102 | 0.032 | 0.102 | 3C-Like protease (SARS coronavirus) inhibitor | 0.084 0.058 DBMET02419 0.079 0.071 DBMET02420 | ||
| 0.093 | 0.023 | 0.125 | Carbamoyl phosphate synthetase inhibitor | 0.119 0.016 DBMET02417 0.125 0.015 DBMET02419 0.125 0.015 DBMET02420 0.097 0.021 DBMET02421 | DBMET02420 | |
| 0.074 | 0.005 | 0.186 | NMDA 2D receptor antagonist | 0.186 0.003 DBMET02419 0.17 0.003 DBMET02420 | DBMET02419 | |
| 0.088 | 0.019 | 0.11 | Ornithine carbamoyltransferase inhibitor | 0.064 0.029 DBMET02417 0.11 0.014 DBMET02419 0.1 0.016 DBMET02420 0.077 0.023 DBMET02421 | DBMET02419 | |
| 0.191 | 0.123 | 0.34 | DNA damaging | 0.34 0.044 DBMET02417 0.181 0.133 DBMET02419 0.184 0.13 DBMET02420 | DBMET02417 | |
| 0.256 | 0.189 | 0.33 | DNA polymerase beta inhibitor | 0.327 0.151 DBMET02419 0.33 0.149 DBMET02420 | DBMET02420 | |
| 0.081 | 0.014 | 0.081 | Thromboxane A2 antagonist | 0.081 0.014 DBMET02419 0.073 0.019 DBMET02420 | ||
| 0.137 | 0.07 | 0.162 | Bone formation stimulant | 0.136 0.071 DBMET02417 0.138 0.069 DBMET02419 0.162 0.051 DBMET02420 | DBMET02420 | |
| 0.076 | 0.009 | 0.084 | Leukotriene C antagonist | 0.084 0.007 DBMET02419 0.08 0.008 DBMET02420 0.067 0.018 DBMET02421 | DBMET02419 | |
| 0.075 | 0.008 | 0.111 | Glutamate (mGluR group III) antagonist | 0.111 0.005 DBMET02419 0.084 0.007 DBMET02420 | DBMET02419 | |
| 0.109 | 0.043 | 0.109 | Antineoplastic alkaloid | 0.092 0.053 DBMET02419 0.091 0.054 DBMET02420 | ||
| 0.073 | 0.008 | 0.122 | Dihydropteroate synthase inhibitor | 0.119 0.004 DBMET02419 0.122 0.004 DBMET02420 0.05 0.017 DBMET02421 | DBMET02420 | |
| 0.085 | 0.02 | 0.143 | Carbonic anhydrase VB inhibitor | 0.123 0.012 DBMET02419 0.143 0.009 DBMET02420 | DBMET02420 | |
| 0.072 | 0.007 | 0.076 | Neuraminidase (Influenza A) inhibitor | 0.074 0.006 DBMET02417 0.075 0.005 DBMET02419 0.076 0.005 DBMET02420 | DBMET02420 | |
| 0.107 | 0.043 | 0.209 | NMDA receptor antagonist | 0.209 0.013 DBMET02419 0.206 0.013 DBMET02420 0.08 0.065 DBMET02421 | DBMET02419 | |
| 0.154 | 0.09 | 0.154 | Antipruritic | 0.131 0.121 DBMET02419 0.134 0.116 DBMET02420 | ||
| 0.068 | 0.005 | 0.074 | Kainate receptor agonist | 0.041 0.028 DBMET02417 0.074 0.004 DBMET02419 0.067 0.005 DBMET02420 0.048 0.016 DBMET02421 | DBMET02419 | |
| 0.076 | 0.012 | 0.122 | Dihydroorotate oxidase inhibitor | 0.122 0.004 DBMET02419 0.12 0.004 DBMET02420 0.055 0.038 DBMET02421 | DBMET02419 | |
| 0.069 | 0.006 | 0.13 | Glutamate (mGluR3) antagonist | 0.13 0.004 DBMET02419 0.106 0.004 DBMET02420 0.035 0.029 DBMET02421 | DBMET02419 | |
| 0.071 | 0.01 | 0.107 | Glutamate (mGluR4) antagonist | 0.107 0.005 DBMET02419 0.081 0.008 DBMET02420 | DBMET02419 | |
| 0.075 | 0.014 | 0.1 | DNA helicase inhibitor | 0.1 0.005 DBMET02419 0.094 0.007 DBMET02420 0.07 0.017 DBMET02421 | DBMET02419 | |
| 0.099 | 0.038 | 0.189 | Adrenaline agonist | 0.177 0.009 DBMET02419 0.189 0.008 DBMET02420 0.071 0.07 DBMET02421 | DBMET02420 | |
| 0.069 | 0.009 | 0.074 | Dopamine beta hydroxylase inhibitor | 0.07 0.008 DBMET02419 0.074 0.006 DBMET02420 | DBMET02420 | |
| 0.065 | 0.005 | 0.099 | Glutamate (mGluR8) agonist | 0.099 0.003 DBMET02419 0.095 0.003 DBMET02420 0.046 0.014 DBMET02421 | DBMET02419 | |
| 0.063 | 0.004 | 0.063 | Elastase 2 inhibitor | |||
| 0.063 | 0.004 | 0.063 | Elastase 2A inhibitor | |||
| 0.064 | 0.005 | 0.081 | Uridine phosphorylase inhibitor | 0.081 0.003 DBMET02417 0.064 0.005 DBMET02419 0.06 0.005 DBMET02420 | DBMET02417 | |
| 0.063 | 0.005 | 0.067 | Retinoid X receptor antagonist | 0.067 0.004 DBMET02419 0.061 0.005 DBMET02420 | DBMET02419 | |
| 0.073 | 0.014 | 0.073 | Potassium channel Kv1.3 blocker | 0.044 0.036 DBMET02419 | ||
| 0.076 | 0.018 | 0.076 | Elastase inhibitor | |||
| 0.112 | 0.054 | 0.178 | Urease inhibitor | 0.17 0.015 DBMET02419 0.178 0.013 DBMET02420 0.094 0.074 DBMET02421 | DBMET02420 | |
| 0.07 | 0.012 | 0.182 | Glucose-6-phosphate isomerase inhibitor | 0.182 0.002 DBMET02417 0.087 0.007 DBMET02419 0.085 0.007 DBMET02420 0.064 0.015 DBMET02421 | DBMET02417 | |
| 0.08 | 0.023 | 0.099 | Prostaglandin F2 alpha antagonist | 0.099 0.012 DBMET02419 0.097 0.013 DBMET02420 | DBMET02419 | |
| 0.065 | 0.008 | 0.077 | Guanylate cyclase inhibitor | 0.077 0.003 DBMET02417 0.074 0.004 DBMET02419 0.072 0.004 DBMET02420 0.048 0.023 DBMET02421 | DBMET02417 | |
| 0.133 | 0.076 | 0.133 | Cytokine production inhibitor | 0.128 0.081 DBMET02419 0.12 0.089 DBMET02420 | ||
| 0.071 | 0.015 | 0.134 | Carbonic anhydrase VII inhibitor | 0.103 0.009 DBMET02419 0.134 0.007 DBMET02420 | DBMET02420 | |
| 0.088 | 0.032 | 0.088 | Sphingosine 1-phosphate receptor 4 agonist | 0.083 0.035 DBMET02419 0.075 0.041 DBMET02420 0.074 0.041 DBMET02421 | ||
| 0.097 | 0.041 | 0.224 | Transcription factor NF kappa B stimulant | 0.224 0.007 DBMET02417 0.08 0.069 DBMET02419 0.081 0.068 DBMET02420 | DBMET02417 | |
| 0.072 | 0.016 | 0.076 | Thromboxane synthase inhibitor | 0.076 0.014 DBMET02419 0.07 0.017 DBMET02420 | DBMET02419 | |
| 0.069 | 0.014 | 0.073 | Adenosine deaminase inhibitor | 0.065 0.016 DBMET02417 0.073 0.012 DBMET02419 0.069 0.014 DBMET02420 | DBMET02419 | |
| 0.064 | 0.009 | 0.098 | Arginase inhibitor | 0.098 0.004 DBMET02417 0.055 0.012 DBMET02419 0.058 0.011 DBMET02420 0.033 0.028 DBMET02421 | DBMET02417 | |
| 0.086 | 0.032 | 0.091 | Carbonic anhydrase inhibitor | 0.077 0.036 DBMET02417 0.087 0.032 DBMET02419 0.091 0.03 DBMET02420 | DBMET02420 | |
| 0.066 | 0.013 | 0.094 | Dihydroorotase inhibitor | 0.094 0.006 DBMET02419 0.077 0.009 DBMET02420 | DBMET02419 | |
| 0.08 | 0.027 | 0.096 | Beta adrenoreceptor antagonist | 0.088 0.022 DBMET02419 0.096 0.018 DBMET02420 | DBMET02420 | |
| 0.095 | 0.042 | 0.095 | Inducible nitric-oxide synthase inhibitor | |||
| 0.117 | 0.065 | 0.145 | Interleukin 8 antagonist | 0.145 0.037 DBMET02419 0.142 0.039 DBMET02420 0.104 0.087 DBMET02421 | DBMET02419 | |
| 0.117 | 0.065 | 0.142 | Transcription factor STAT6 inhibitor | 0.142 0.03 DBMET02419 0.137 0.036 DBMET02420 0.102 0.101 DBMET02421 | DBMET02419 | |
| 0.063 | 0.011 | 0.063 | Benzodiazepine antagonist | |||
| 0.245 | 0.194 | 0.334 | DNA directed DNA polymerase inhibitor | 0.332 0.146 DBMET02419 0.334 0.145 DBMET02420 | DBMET02420 | |
| 0.096 | 0.046 | 0.119 | Interleukin 5 antagonist | 0.104 0.037 DBMET02417 0.119 0.024 DBMET02419 0.119 0.025 DBMET02420 | DBMET02420 | |
| 0.076 | 0.026 | 0.088 | MDM2 inhibitor | 0.088 0.013 DBMET02419 0.084 0.016 DBMET02420 | DBMET02419 | |
| 0.06 | 0.01 | 0.069 | Farnesoid X receptor agonist | 0.069 0.007 DBMET02419 0.063 0.009 DBMET02420 | DBMET02419 | |
| 0.055 | 0.005 | 0.056 | Retinoid X alpha receptor antagonist | 0.056 0.004 DBMET02419 0.05 0.006 DBMET02420 | DBMET02419 | |
| 0.09 | 0.04 | 0.135 | Na+ K+ transporting ATPase inhibitor | 0.135 0.01 DBMET02417 0.096 0.035 DBMET02419 0.101 0.031 DBMET02420 | DBMET02417 | |
| 0.054 | 0.005 | 0.054 | Retinoid X beta receptor agonist | 0.053 0.005 DBMET02419 0.04 0.006 DBMET02420 | ||
| 0.068 | 0.019 | 0.068 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.057 | 0.009 | 0.057 | Prostaglandin agonist | 0.056 0.009 DBMET02419 0.053 0.009 DBMET02420 | ||
| 0.061 | 0.013 | 0.061 | Microtubule stabilization | 0.059 0.016 DBMET02417 | ||
| 0.053 | 0.005 | 0.053 | Retinoid X gamma receptor agonist | 0.052 0.005 DBMET02419 0.041 0.007 DBMET02420 | ||
| 0.153 | 0.105 | 0.449 | Amyloid beta aggregation inhibitor | 0.208 0.073 DBMET02417 0.353 0.034 DBMET02419 0.449 0.019 DBMET02420 | DBMET02420 | |
| 0.055 | 0.007 | 0.055 | Free fatty acid receptor 1 antagonist | 0.049 0.009 DBMET02419 0.043 0.013 DBMET02420 | ||
| 0.081 | 0.035 | 0.086 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.086 0.027 DBMET02419 0.074 0.05 DBMET02420 | DBMET02419 | |
| 0.053 | 0.006 | 0.054 | Kynurenine 3 monooxygenase inhibitor | 0.054 0.006 DBMET02419 0.041 0.009 DBMET02420 | DBMET02419 | |
| 0.117 | 0.071 | 0.174 | Beta amyloid protein antagonist | 0.174 0.027 DBMET02417 0.103 0.085 DBMET02419 0.124 0.063 DBMET02420 | DBMET02417 | |
| 0.051 | 0.005 | 0.051 | Prostaglandin EP2 agonist | 0.047 0.006 DBMET02419 0.047 0.006 DBMET02420 | ||
| 0.072 | 0.026 | 0.15 | Aldose reductase inhibitor | 0.15 0.011 DBMET02417 0.08 0.023 DBMET02419 0.108 0.016 DBMET02420 0.09 0.02 DBMET02421 | DBMET02417 | |
| 0.11 | 0.065 | 0.161 | Acetylcholine release stimulant | 0.161 0.011 DBMET02417 0.117 0.053 DBMET02419 0.11 0.066 DBMET02420 | DBMET02417 | |
| 0.084 | 0.039 | 0.084 | Sphingosine 1-phosphate receptor antagonist | 0.083 0.041 DBMET02419 0.081 0.043 DBMET02420 | ||
| 0.06 | 0.016 | 0.133 | Kainate receptor antagonist | 0.133 0.005 DBMET02419 0.121 0.005 DBMET02420 | DBMET02419 | |
| 0.05 | 0.006 | 0.05 | Methionyl aminopeptidase 1 inhibitor | 0.036 0.017 DBMET02419 0.03 0.026 DBMET02420 | ||
| 0.055 | 0.011 | 0.055 | Angiotensin AT1 receptor antagonist | 0.055 0.012 DBMET02419 0.047 0.022 DBMET02420 | ||
| 0.053 | 0.009 | 0.059 | Leukotriene C4 antagonist | 0.059 0.006 DBMET02419 0.055 0.008 DBMET02420 0.044 0.017 DBMET02421 | DBMET02419 | |
| 0.059 | 0.016 | 0.075 | Leukotriene A4 hydrolase inhibitor | 0.075 0.01 DBMET02419 0.058 0.016 DBMET02420 | DBMET02419 | |
| 0.094 | 0.051 | 0.118 | Androgen antagonist | 0.106 0.043 DBMET02419 0.118 0.034 DBMET02420 | DBMET02420 | |
| 0.172 | 0.13 | 0.192 | 5 Hydroxytryptamine 3E antagonist | 0.192 0.078 DBMET02419 0.176 0.118 DBMET02420 | DBMET02419 | |
| 0.06 | 0.018 | 0.06 | Adenylate cyclase 1 inhibitor | 0.05 0.026 DBMET02419 0.048 0.03 DBMET02420 | ||
| 0.046 | 0.004 | 0.077 | Retinoic acid receptor antagonist | 0.077 0.003 DBMET02419 0.075 0.003 DBMET02420 | DBMET02419 | |
| 0.068 | 0.027 | 0.072 | Sphingosine kinase inhibitor | 0.07 0.025 DBMET02419 0.072 0.023 DBMET02420 | DBMET02420 | |
| 0.046 | 0.004 | 0.085 | Retinoic acid alpha receptor antagonist | 0.085 0.003 DBMET02419 0.08 0.003 DBMET02420 | DBMET02419 | |
| 0.112 | 0.071 | 0.315 | Estrogen antagonist | 0.1 0.099 DBMET02417 0.175 0.017 DBMET02419 0.315 0.005 DBMET02420 0.108 0.079 DBMET02421 | DBMET02420 | |
| 0.087 | 0.047 | 0.117 | Glutamate receptor agonist | 0.117 0.028 DBMET02419 0.089 0.045 DBMET02420 | DBMET02419 | |
| 0.237 | 0.196 | 0.273 | Transcription factor inhibitor | 0.273 0.171 DBMET02419 0.252 0.185 DBMET02420 | DBMET02419 | |
| 0.087 | 0.046 | 0.089 | Thioredoxin reductase inhibitor | 0.085 0.051 DBMET02419 0.089 0.042 DBMET02420 | DBMET02420 | |
| 0.068 | 0.027 | 0.199 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.199 0.007 DBMET02417 0.09 0.017 DBMET02419 0.085 0.018 DBMET02420 0.069 0.026 DBMET02421 | DBMET02417 | |
| 0.044 | 0.004 | 0.044 | Lysophosphatidic acid 1 receptor antagonist | 0.035 0.005 DBMET02419 0.031 0.006 DBMET02420 | ||
| 0.112 | 0.072 | 0.112 | Proteasome inhibitor | 0.104 0.082 DBMET02419 0.103 0.083 DBMET02420 | ||
| 0.062 | 0.022 | 0.062 | Prolyl endopeptidase inhibitor | 0.048 0.04 DBMET02419 | ||
| 0.048 | 0.009 | 0.05 | Liver X receptor beta antagonist | 0.047 0.009 DBMET02419 0.05 0.008 DBMET02420 | DBMET02420 | |
| 0.13 | 0.091 | 0.166 | Cytidine deaminase inhibitor | 0.166 0.064 DBMET02419 0.141 0.082 DBMET02420 | DBMET02419 | |
| 0.058 | 0.018 | 0.058 | Sphingosine 1-phosphate receptor agonist | 0.052 0.023 DBMET02419 0.044 0.031 DBMET02420 | ||
| 0.054 | 0.014 | 0.076 | Kainate receptor 2 antagonist | 0.076 0.007 DBMET02419 0.062 0.011 DBMET02420 | DBMET02419 | |
| 0.048 | 0.009 | 0.06 | Glutamate (mGluR8) antagonist | 0.06 0.005 DBMET02419 0.055 0.007 DBMET02420 0.035 0.026 DBMET02421 | DBMET02419 | |
| 0.042 | 0.004 | 0.053 | Retinoic acid gamma receptor agonist | 0.053 0.003 DBMET02419 0.051 0.003 DBMET02420 | DBMET02419 | |
| 0.046 | 0.008 | 0.069 | Leukotriene B4 receptor 1 antagonist | 0.069 0.004 DBMET02419 0.065 0.005 DBMET02420 | DBMET02419 | |
| 0.048 | 0.01 | 0.048 | Peroxisome proliferator-activated receptor delta antagonist | 0.036 0.019 DBMET02419 0.037 0.018 DBMET02420 | ||
| 0.041 | 0.005 | 0.053 | Nicotinic acid receptor 2 antagonist | 0.053 0.004 DBMET02419 0.05 0.004 DBMET02420 | DBMET02419 | |
| 0.077 | 0.041 | 0.094 | Prostaglandin-E synthase inhibitor | 0.094 0.03 DBMET02419 0.083 0.037 DBMET02420 | DBMET02419 | |
| 0.068 | 0.032 | 0.077 | Androgen agonist | 0.073 0.028 DBMET02419 0.077 0.025 DBMET02420 | DBMET02420 | |
| 0.04 | 0.004 | 0.05 | Retinoic acid beta receptor agonist | 0.05 0.004 DBMET02419 0.043 0.004 DBMET02420 | DBMET02419 | |
| 0.064 | 0.028 | 0.081 | Lipocortins synthesis agonist | 0.081 0.013 DBMET02417 0.054 0.05 DBMET02419 0.054 0.053 DBMET02420 | DBMET02417 | |
| 0.062 | 0.027 | 0.127 | Dihydroorotate dehydrogenase inhibitor | 0.127 0.006 DBMET02419 0.108 0.009 DBMET02420 | DBMET02419 | |
| 0.04 | 0.004 | 0.07 | Vanilloid 2 agonist | 0.07 0.002 DBMET02417 0.042 0.004 DBMET02419 0.047 0.003 DBMET02420 | DBMET02417 | |
| 0.045 | 0.009 | 0.045 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.039 | 0.005 | 0.057 | Leukotriene B4 receptor 2 antagonist | 0.027 0.011 DBMET02417 0.057 0.004 DBMET02419 0.056 0.004 DBMET02420 | DBMET02419 | |
| 0.137 | 0.102 | 0.235 | Heat shock protein 90 alpha antagonist | 0.229 0.035 DBMET02419 0.235 0.032 DBMET02420 | DBMET02420 | |
| 0.116 | 0.082 | 0.346 | DNA repair enzyme inhibitor | 0.346 0.004 DBMET02417 0.141 0.04 DBMET02419 0.136 0.047 DBMET02420 0.107 0.105 DBMET02421 | DBMET02417 | |
| 0.087 | 0.053 | 0.168 | Myeloperoxidase inhibitor | 0.158 0.01 DBMET02419 0.168 0.008 DBMET02420 | DBMET02420 | |
| 0.049 | 0.016 | 0.049 | Membrane dipeptidase inhibitor | 0.047 0.019 DBMET02419 0.044 0.022 DBMET02420 0.036 0.033 DBMET02421 | ||
| 0.047 | 0.014 | 0.083 | RNA-directed RNA polymerase inhibitor | 0.083 0.006 DBMET02419 0.074 0.007 DBMET02420 | DBMET02419 | |
| 0.089 | 0.058 | 0.147 | ATPase (Vacuolar H+) inhibitor | 0.147 0.008 DBMET02417 0.081 0.077 DBMET02419 0.083 0.072 DBMET02420 | DBMET02417 | |
| 0.043 | 0.011 | 0.043 | Angiotensin II receptor antagonist | 0.043 0.011 DBMET02419 0.036 0.02 DBMET02420 | ||
| 0.054 | 0.023 | 0.058 | Carnitine palmitoyltransferase 1B inhibitor | 0.058 0.02 DBMET02419 0.048 0.032 DBMET02420 | DBMET02419 | |
| 0.064 | 0.033 | 0.082 | Beta 2 adrenoreceptor agonist | 0.079 0.01 DBMET02419 0.082 0.008 DBMET02420 0.063 0.039 DBMET02421 | DBMET02420 | |
| 0.084 | 0.053 | 0.095 | Caspase 7 inhibitor | 0.095 0.034 DBMET02419 0.089 0.043 DBMET02420 | DBMET02419 | |
| 0.049 | 0.019 | 0.074 | Beta adrenoreceptor agonist | 0.069 0.005 DBMET02419 0.074 0.005 DBMET02420 0.044 0.038 DBMET02421 | DBMET02420 | |
| 0.034 | 0.004 | 0.034 | Retinoid X beta receptor antagonist | 0.034 0.004 DBMET02419 0.029 0.004 DBMET02420 | ||
| 0.085 | 0.055 | 0.157 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.148 0.015 DBMET02419 0.157 0.013 DBMET02420 | DBMET02420 | |
| 0.036 | 0.006 | 0.061 | Glutamate (mGluR1) agonist | 0.061 0.004 DBMET02419 0.059 0.004 DBMET02420 | DBMET02419 | |
| 0.154 | 0.124 | 0.154 | Platelet aggregation inhibitor | |||
| 0.063 | 0.033 | 0.068 | Carbonic anhydrase II inhibitor | 0.053 0.041 DBMET02417 0.065 0.032 DBMET02419 0.068 0.03 DBMET02420 | DBMET02420 | |
| 0.061 | 0.032 | 0.129 | Carbonic anhydrase XII inhibitor | 0.129 0.015 DBMET02417 0.086 0.023 DBMET02419 0.088 0.023 DBMET02420 | DBMET02417 | |
| 0.055 | 0.026 | 0.083 | Squalene epoxidase inhibitor | 0.051 0.032 DBMET02417 0.077 0.011 DBMET02419 0.083 0.009 DBMET02420 | DBMET02420 | |
| 0.04 | 0.011 | 0.067 | Purinergic P2Y14 antagonist | 0.067 0.005 DBMET02419 0.051 0.007 DBMET02420 | DBMET02419 | |
| 0.041 | 0.012 | 0.044 | Lysophosphatidic acid 2 receptor antagonist | 0.044 0.01 DBMET02419 0.04 0.013 DBMET02420 | DBMET02419 | |
| 0.062 | 0.034 | 0.068 | Carbonic anhydrase I inhibitor | 0.054 0.04 DBMET02417 0.067 0.03 DBMET02419 0.068 0.03 DBMET02420 | DBMET02420 | |
| 0.055 | 0.028 | 0.189 | Phosphorylase inhibitor | 0.189 0.005 DBMET02417 0.114 0.011 DBMET02419 0.12 0.01 DBMET02420 | DBMET02417 | |
| 0.058 | 0.03 | 0.073 | Autotaxin inhibitor | 0.073 0.021 DBMET02419 0.064 0.026 DBMET02420 | DBMET02419 | |
| 0.04 | 0.013 | 0.04 | Cholesterol ester transfer protein antagonist | 0.029 0.025 DBMET02419 0.028 0.027 DBMET02420 | ||
| 0.058 | 0.031 | 0.246 | Estrogen agonist | 0.101 0.017 DBMET02417 0.103 0.016 DBMET02419 0.246 0.006 DBMET02420 | DBMET02420 | |
| 0.035 | 0.009 | 0.042 | Prostaglandin H2 antagonist | 0.042 0.005 DBMET02419 0.038 0.007 DBMET02420 0.026 0.017 DBMET02421 | DBMET02419 | |
| 0.034 | 0.008 | 0.036 | Retinoid X gamma receptor antagonist | 0.036 0.006 DBMET02419 0.034 0.008 DBMET02420 | DBMET02419 | |
| 0.039 | 0.013 | 0.066 | ATP citrate lysase inhibitor | 0.057 0.005 DBMET02419 0.066 0.005 DBMET02420 0.032 0.022 DBMET02421 | DBMET02420 | |
| 0.19 | 0.164 | 0.327 | Prostaglandin dehydrogenase inhibitor | 0.327 0.091 DBMET02419 0.311 0.097 DBMET02420 | DBMET02419 | |
| 0.038 | 0.012 | 0.04 | Leukotriene D4 antagonist | 0.04 0.012 DBMET02419 0.038 0.013 DBMET02420 | DBMET02419 | |
| 0.227 | 0.202 | 0.662 | Alpha-glucosidase inhibitor | 0.662 0.041 DBMET02417 0.368 0.128 DBMET02419 0.41 0.11 DBMET02420 | DBMET02417 | |
| 0.056 | 0.032 | 0.056 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.06 | 0.036 | 0.076 | Beta 1 adrenoreceptor antagonist | 0.071 0.025 DBMET02419 0.076 0.021 DBMET02420 | DBMET02420 | |
| 0.047 | 0.023 | 0.047 | Sphingosine 1-phosphate receptor 1 agonist | 0.04 0.033 DBMET02419 | ||
| 0.064 | 0.04 | 0.119 | NMDA 2C receptor antagonist | 0.119 0.011 DBMET02419 0.117 0.011 DBMET02420 | DBMET02419 | |
| 0.04 | 0.016 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.013 DBMET02419 0.036 0.023 DBMET02420 0.036 0.025 DBMET02421 | DBMET02419 | |
| 0.17 | 0.146 | 0.488 | Peptidyltransferase inhibitor | 0.488 0.004 DBMET02417 0.225 0.071 DBMET02419 0.238 0.06 DBMET02420 0.298 0.025 DBMET02421 | DBMET02417 | |
| 0.027 | 0.004 | 0.079 | Retinoic acid receptor gamma antagonist | 0.079 0.003 DBMET02419 0.076 0.003 DBMET02420 | DBMET02419 | |
| 0.038 | 0.014 | 0.039 | Calcium-independent phospholipase A2 inhibitor | 0.039 0.012 DBMET02419 0.035 0.021 DBMET02420 | DBMET02419 | |
| 0.057 | 0.033 | 0.194 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.167 0.004 DBMET02419 0.194 0.004 DBMET02420 0.049 0.044 DBMET02421 | DBMET02420 | |
| 0.092 | 0.069 | 0.207 | Phosphodiesterase 6D inhibitor | 0.207 0.004 DBMET02417 0.107 0.04 DBMET02419 0.108 0.039 DBMET02420 | DBMET02417 | |
| 0.032 | 0.008 | 0.032 | 5-Alpha-reductase 1 inhibitor | 0.026 0.009 DBMET02419 0.021 0.01 DBMET02420 | ||
| 0.028 | 0.005 | 0.035 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DBMET02417 0.032 0.004 DBMET02419 0.035 0.004 DBMET02420 | DBMET02420 | |
| 0.041 | 0.018 | 0.081 | Phosphoglycerate kinase inhibitor | 0.032 0.028 DBMET02417 0.08 0.008 DBMET02419 0.081 0.008 DBMET02420 | DBMET02420 | |
| 0.043 | 0.021 | 0.057 | TRPM8 blocker | 0.057 0.013 DBMET02419 0.044 0.02 DBMET02420 | DBMET02419 | |
| 0.026 | 0.004 | 0.088 | Retinoic acid beta receptor antagonist | 0.088 0.003 DBMET02419 0.08 0.003 DBMET02420 | DBMET02419 | |
| 0.04 | 0.018 | 0.072 | Squalene synthetase inhibitor | 0.072 0.009 DBMET02417 | DBMET02417 | |
| 0.041 | 0.019 | 0.041 | Vanilloid 3 antagonist | 0.039 0.024 DBMET02419 | ||
| 0.032 | 0.009 | 0.076 | Kainate receptor 1 antagonist | 0.076 0.004 DBMET02419 0.062 0.005 DBMET02420 | DBMET02419 | |
| 0.059 | 0.037 | 0.088 | Fatty acid synthase inhibitor | 0.078 0.019 DBMET02419 0.088 0.015 DBMET02420 | DBMET02420 | |
| 0.047 | 0.026 | 0.07 | AICAR transformylase inhibitor | 0.07 0.01 DBMET02419 0.066 0.011 DBMET02420 | DBMET02419 | |
| 0.039 | 0.018 | 0.039 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.048 | 0.027 | 0.31 | Mannosidase inhibitor | 0.31 0.002 DBMET02417 0.078 0.009 DBMET02419 0.071 0.011 DBMET02420 0.059 0.017 DBMET02421 | DBMET02417 | |
| 0.031 | 0.01 | 0.038 | Prostaglandin E2 agonist | 0.038 0.008 DBMET02419 0.036 0.008 DBMET02420 | DBMET02419 | |
| 0.025 | 0.005 | 0.028 | Estrogen-related receptor gamma agonist | 0.026 0.005 DBMET02419 0.028 0.005 DBMET02420 0.023 0.007 DBMET02421 | DBMET02420 | |
| 0.076 | 0.056 | 0.292 | Topoisomerase II alpha inhibitor | 0.292 0.008 DBMET02417 0.12 0.03 DBMET02419 0.179 0.018 DBMET02420 | DBMET02417 | |
| 0.076 | 0.056 | 0.133 | Estrogen receptor alpha antagonist | 0.111 0.022 DBMET02419 0.133 0.015 DBMET02420 | DBMET02420 | |
| 0.034 | 0.013 | 0.042 | Prostaglandin EP4 antagonist | 0.042 0.01 DBMET02419 0.033 0.014 DBMET02420 | DBMET02419 | |
| 0.025 | 0.005 | 0.052 | Antibiotic Anthracycline-like | 0.052 0.002 DBMET02417 0.024 0.005 DBMET02419 0.024 0.006 DBMET02420 | DBMET02417 | |
| 0.058 | 0.038 | 0.086 | Carbonic anhydrase IX inhibitor | 0.086 0.024 DBMET02417 0.072 0.031 DBMET02419 0.072 0.031 DBMET02420 | DBMET02417 | |
| 0.127 | 0.108 | 0.127 | Pregnane X receptor agonist | 0.124 0.118 DBMET02419 | ||
| 0.055 | 0.037 | 0.055 | Angiotensin-converting enzyme inhibitor | 0.053 0.041 DBMET02419 0.053 0.041 DBMET02420 | ||
| 0.024 | 0.006 | 0.055 | Nicotinic acid receptor 1 antagonist | 0.055 0.002 DBMET02419 0.054 0.002 DBMET02420 | DBMET02419 | |
| 0.064 | 0.045 | 0.064 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.046 DBMET02419 0.059 0.054 DBMET02420 | ||
| 0.076 | 0.058 | 0.113 | MAP kinase kinase 7 inhibitor | 0.11 0.007 DBMET02419 0.113 0.005 DBMET02420 0.08 0.047 DBMET02421 | DBMET02420 | |
| 0.031 | 0.014 | 0.044 | Estrogen-related receptor gamma antagonist | 0.044 0.004 DBMET02419 0.044 0.004 DBMET02420 0.03 0.016 DBMET02421 | DBMET02420 | |
| 0.047 | 0.029 | 0.06 | Purinergic P2Y antagonist | 0.06 0.019 DBMET02419 0.042 0.034 DBMET02420 | DBMET02419 | |
| 0.037 | 0.019 | 0.04 | Carnitine palmitoyltransferase 1 inhibitor | 0.04 0.016 DBMET02419 0.032 0.026 DBMET02420 | DBMET02419 | |
| 0.027 | 0.01 | 0.043 | Glutamate (mGluR1a) agonist | 0.043 0.005 DBMET02419 0.041 0.005 DBMET02420 | DBMET02419 | |
| 0.025 | 0.008 | 0.025 | Caspase 8 inhibitor | 0.024 0.009 DBMET02419 0.021 0.011 DBMET02420 | ||
| 0.027 | 0.01 | 0.05 | Beta 1 adrenoreceptor agonist | 0.043 0.004 DBMET02419 0.05 0.004 DBMET02420 | DBMET02420 | |
| 0.037 | 0.02 | 0.04 | Carnitine palmitoyltransferase inhibitor | 0.04 0.016 DBMET02419 0.032 0.027 DBMET02420 | DBMET02419 | |
| 0.052 | 0.035 | 0.164 | NMDA 2A receptor antagonist | 0.164 0.006 DBMET02419 0.153 0.007 DBMET02420 0.045 0.043 DBMET02421 | DBMET02419 | |
| 0.09 | 0.073 | 0.191 | Protein kinase (CK2) inhibitor | 0.191 0.02 DBMET02419 0.183 0.022 DBMET02420 | DBMET02419 | |
| 0.071 | 0.055 | 0.095 | CDC25A inhibitor | 0.095 0.031 DBMET02419 0.094 0.031 DBMET02420 | DBMET02419 | |
| 0.077 | 0.061 | 0.193 | Glycine receptor antagonist | 0.193 0.004 DBMET02417 0.119 0.019 DBMET02419 0.104 0.028 DBMET02420 0.085 0.05 DBMET02421 | DBMET02417 | |
| 0.029 | 0.012 | 0.029 | Lysophosphatidic acid receptor 1 agonist | 0.027 0.014 DBMET02419 0.024 0.02 DBMET02420 | ||
| 0.093 | 0.077 | 0.35 | Topoisomerase I inhibitor | 0.35 0.008 DBMET02417 0.114 0.06 DBMET02419 0.167 0.035 DBMET02420 | DBMET02417 | |
| 0.03 | 0.014 | 0.038 | Calcium-sensing receptor agonist | 0.038 0.008 DBMET02419 0.031 0.012 DBMET02420 | DBMET02419 | |
| 0.043 | 0.027 | 0.051 | Liver X receptor alpha agonist | 0.048 0.021 DBMET02419 0.051 0.019 DBMET02420 | DBMET02420 | |
| 0.051 | 0.035 | 0.07 | Beta 2 adrenoreceptor antagonist | 0.065 0.02 DBMET02419 0.07 0.016 DBMET02420 | DBMET02420 | |
| 0.034 | 0.019 | 0.07 | HCV NS5B polymerase inhibitor | 0.07 0.007 DBMET02419 0.07 0.007 DBMET02420 | DBMET02420 | |
| 0.089 | 0.074 | 0.151 | Sphingomyelinase inhibitor | 0.151 0.024 DBMET02417 0.103 0.056 DBMET02419 0.096 0.065 DBMET02420 | DBMET02417 | |
| 0.086 | 0.071 | 0.128 | Breast cancer-resistant protein inhibitor | 0.095 0.06 DBMET02419 0.128 0.034 DBMET02420 | DBMET02420 | |
| 0.044 | 0.029 | 0.044 | Dihydrofolate reductase inhibitor | 0.041 0.037 DBMET02419 0.041 0.036 DBMET02420 | ||
| 0.021 | 0.007 | 0.021 | Carbonic anhydrase VIII inhibitor | 0.021 0.007 DBMET02419 0.02 0.008 DBMET02420 | ||
| 0.021 | 0.007 | 0.021 | Carbonic anhydrase X inhibitor | 0.021 0.007 DBMET02419 0.02 0.008 DBMET02420 | ||
| 0.025 | 0.011 | 0.038 | Prostaglandin EP1 antagonist | 0.038 0.008 DBMET02419 0.03 0.01 DBMET02420 | DBMET02419 | |
| 0.03 | 0.017 | 0.03 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.019 DBMET02417 0.028 0.019 DBMET02419 | ||
| 0.023 | 0.011 | 0.027 | 5-Alpha-reductase 2 inhibitor | 0.027 0.009 DBMET02419 0.025 0.01 DBMET02420 | DBMET02419 | |
| 0.021 | 0.008 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 DBMET02417 0.022 0.006 DBMET02419 0.022 0.006 DBMET02420 0.017 0.015 DBMET02421 | DBMET02420 | |
| 0.036 | 0.023 | 0.06 | Glutamate (mGluR group II) agonist | 0.06 0.012 DBMET02419 0.05 0.015 DBMET02420 | DBMET02419 | |
| 0.052 | 0.04 | 0.312 | Alpha-mannosidase inhibitor | 0.312 0.002 DBMET02417 0.075 0.014 DBMET02419 0.072 0.015 DBMET02420 0.068 0.018 DBMET02421 | DBMET02417 | |
| 0.111 | 0.099 | 0.111 | Calcium channel blocker | |||
| 0.024 | 0.013 | 0.036 | Prostaglandin F2 alpha agonist | 0.022 0.017 DBMET02417 0.036 0.006 DBMET02419 0.036 0.006 DBMET02420 0.021 0.018 DBMET02421 | DBMET02420 | |
| 0.027 | 0.016 | 0.04 | Methionyl aminopeptidase 2 inhibitor | 0.04 0.009 DBMET02419 0.028 0.015 DBMET02420 | DBMET02419 | |
| 0.016 | 0.005 | 0.032 | Glutamate (mGluR6) agonist | 0.03 0.003 DBMET02419 0.032 0.003 DBMET02420 | DBMET02420 | |
| 0.08 | 0.07 | 0.088 | Vanilloid agonist | 0.088 0.051 DBMET02420 | DBMET02420 | |
| 0.059 | 0.049 | 0.076 | Heme oxygenase stimulant | 0.076 0.018 DBMET02419 0.073 0.021 DBMET02420 | DBMET02419 | |
| 0.061 | 0.052 | 0.065 | Calcium channel P-type blocker | 0.065 0.039 DBMET02419 0.062 0.049 DBMET02420 | DBMET02419 | |
| 0.041 | 0.033 | 0.066 | Nerve growth factor antagonist | 0.066 0.006 DBMET02419 0.053 0.014 DBMET02420 | DBMET02419 | |
| 0.018 | 0.009 | 0.039 | Prostaglandin EP4 agonist | 0.039 0.006 DBMET02419 0.032 0.007 DBMET02420 | DBMET02419 | |
| 0.091 | 0.082 | 0.099 | Glutamate (mGluR7) agonist | 0.099 0.061 DBMET02419 0.091 0.081 DBMET02420 | DBMET02419 | |
| 0.024 | 0.017 | 0.039 | NMDA receptor glycine site antagonist | 0.039 0.009 DBMET02419 0.032 0.011 DBMET02420 | DBMET02419 | |
| 0.058 | 0.052 | 0.058 | Caspase 9 inhibitor | |||
| 0.017 | 0.011 | 0.017 | G-protein-coupled receptor 120 agonist | |||
| 0.017 | 0.011 | 0.017 | Vitamin D receptor agonist | |||
| 0.015 | 0.009 | 0.015 | Angiotensin AT1B receptor antagonist | 0.015 0.008 DBMET02419 | ||
| 0.04 | 0.035 | 0.137 | NMDA receptor subunit 3B antagonist | 0.137 0.007 DBMET02419 0.128 0.008 DBMET02420 0.043 0.032 DBMET02421 | DBMET02419 | |
| 0.03 | 0.025 | 0.052 | Glutamate (mGluR2) agonist | 0.052 0.013 DBMET02419 0.042 0.017 DBMET02420 | DBMET02419 | |
| 0.087 | 0.083 | 0.087 | Nitric-oxide synthase inhibitor | |||
| 0.013 | 0.009 | 0.013 | Lysophosphatidic acid receptor 3 agonist | 0.012 0.011 DBMET02419 | ||
| 0.029 | 0.025 | 0.032 | Caspase 6 inhibitor | 0.032 0.018 DBMET02419 0.029 0.025 DBMET02420 | DBMET02419 | |
| 0.09 | 0.086 | 0.093 | Folate antagonist | 0.093 0.08 DBMET02417 | DBMET02417 | |
| 0.037 | 0.033 | 0.062 | AMPA 4 receptor antagonist | 0.062 0.009 DBMET02419 0.056 0.011 DBMET02420 | DBMET02419 | |
| 0.041 | 0.037 | 0.049 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.027 DBMET02419 0.049 0.026 DBMET02420 | DBMET02420 | |
| 0.032 | 0.028 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.04 0.016 DBMET02419 0.038 0.018 DBMET02420 | DBMET02419 | |
| 0.046 | 0.043 | 0.046 | Diacylglycerol O-acyltransferase inhibitor | 0.046 0.043 DBMET02419 | ||
| 0.065 | 0.062 | 0.065 | Epoxide hydrolase inhibitor | |||
| 0.008 | 0.006 | 0.013 | Mannitol 2-dehydrogenase inhibitor | 0.013 0.003 DBMET02419 0.012 0.004 DBMET02420 | DBMET02419 | |
| 0.054 | 0.052 | 0.084 | Heat shock protein 90 beta antagonist | 0.077 0.022 DBMET02419 0.084 0.018 DBMET02420 | DBMET02420 | |
| 0.012 | 0.01 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.038 | 0.036 | 0.061 | CF transmembrane conductance regulator antagonist | 0.061 0.004 DBMET02419 0.057 0.005 DBMET02420 | DBMET02419 | |
| 0.01 | 0.008 | 0.012 | Thromboxane agonist | 0.012 0.006 DBMET02419 0.012 0.007 DBMET02420 | DBMET02420 | |
| 0.034 | 0.033 | 0.041 | Glutamate (mGluR group II) antagonist | 0.041 0.023 DBMET02419 | DBMET02419 | |
| 0.039 | 0.038 | 0.065 | DNA gyrase subunit A inhibitor | 0.065 0.008 DBMET02419 0.064 0.009 DBMET02420 | DBMET02419 | |
| 0.03 | 0.029 | 0.043 | Purinergic P2Y2 antagonist | 0.043 0.014 DBMET02419 0.04 0.016 DBMET02420 | DBMET02419 | |
| 0.016 | 0.015 | 0.039 | Telomerase stimulant | 0.039 0.002 DBMET02417 0.019 0.009 DBMET02419 0.019 0.009 DBMET02420 | DBMET02417 | |
| 0.034 | 0.033 | 0.043 | Integrin alpha2 antagonist | 0.043 0.018 DBMET02419 0.036 0.027 DBMET02420 | DBMET02419 | |
| 0.052 | 0.051 | 0.052 | Carbonic anhydrase stimulant | |||
| 0.038 | 0.037 | 0.041 | Sphingosine kinase 1 inhibitor | 0.041 0.03 DBMET02419 0.039 0.034 DBMET02420 | DBMET02419 | |
| 0.021 | 0.021 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 DBMET02417 0.023 0.014 DBMET02419 0.022 0.016 DBMET02420 | DBMET02417 | |
| 0.024 | 0.023 | 0.054 | Thyroid hormone agonist | 0.042 0.005 DBMET02419 0.054 0.004 DBMET02420 0.046 0.005 DBMET02421 | DBMET02420 | |
| 0.051 | 0.051 | 0.059 | Sphingosine 1-phosphate receptor 1 antagonist | 0.059 0.031 DBMET02419 0.059 0.031 DBMET02420 | DBMET02420 | |
| 0.024 | 0.024 | 0.03 | Integrin alpha2beta1 antagonist | 0.03 0.012 DBMET02419 0.024 0.023 DBMET02420 | DBMET02419 | |
| 0.029 | 0.031 | 0.032 | Liver X receptor beta agonist | 0.032 0.024 DBMET02419 0.032 0.025 DBMET02420 | DBMET02420 | |
| 0.051 | 0.053 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.06 0.025 DBMET02419 0.055 0.039 DBMET02420 | DBMET02419 | |
| 0.004 | 0.007 | 0.011 | Insulin like growth factor 3 antagonist | 0.011 0.003 DBMET02419 0.011 0.003 DBMET02420 | DBMET02420 | |
| 0.026 | 0.029 | 0.032 | Prostaglandin D2 agonist | 0.031 0.02 DBMET02419 0.032 0.02 DBMET02420 | DBMET02420 | |
| 0.087 | 0.09 | 0.169 | Protein kinase (CK2) alpha inhibitor | 0.169 0.033 DBMET02419 0.169 0.033 DBMET02420 | DBMET02420 | |
| 0.173 | 0.176 | 0.209 | Neuropeptide Y2 antagonist | 0.209 0.104 DBMET02419 0.202 0.115 DBMET02420 | DBMET02419 | |
| 0.014 | 0.018 | 0.018 | Aminopeptidase A inhibitor | 0.018 0.013 DBMET02419 0.017 0.014 DBMET02420 | DBMET02419 | |
| 0.117 | 0.121 | 0.194 | Heat shock protein 90 antagonist | 0.185 0.046 DBMET02419 0.194 0.041 DBMET02420 | DBMET02420 | |
| 0.084 | 0.088 | 0.174 | Falcipain 3 inhibitor | 0.174 0.026 DBMET02419 0.16 0.032 DBMET02420 | DBMET02419 | |
| 0.037 | 0.042 | 0.058 | Geranyltranstransferase inhibitor | 0.058 0.015 DBMET02419 0.052 0.021 DBMET02420 | DBMET02419 | |
| 0.02 | 0.025 | 0.023 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.019 DBMET02419 0.023 0.018 DBMET02420 | DBMET02420 | |
| 0.03 | 0.035 | 0.112 | NMDA receptor subunit 3A antagonist | 0.112 0.007 DBMET02419 0.107 0.008 DBMET02420 0.033 0.031 DBMET02421 | DBMET02419 | |
| 0.177 | 0.182 | 0.217 | Thyroid hormone antagonist | 0.217 0.147 DBMET02419 0.211 0.152 DBMET02420 | DBMET02419 | |
| 0.025 | 0.03 | 0.031 | Liver X receptor alpha antagonist | 0.031 0.018 DBMET02420 | DBMET02420 | |
| 0.095 | 0.101 | 0.447 | Cell adhesion inhibitor | 0.447 0.005 DBMET02417 0.1 0.089 DBMET02419 | DBMET02417 | |
| 0.013 | 0.019 | 0.071 | Ileal bile acid transport inhibitor | 0.071 0.003 DBMET02417 | DBMET02417 | |
| 0.064 | 0.07 | 0.334 | Antineoplastic antibiotic | 0.334 0.008 DBMET02417 0.077 0.06 DBMET02420 | DBMET02417 | |
| 0.045 | 0.052 | 0.061 | Aromatase inhibitor | 0.053 0.046 DBMET02419 0.061 0.041 DBMET02420 | DBMET02420 | |
| 0.009 | 0.016 | 0.028 | Egl nine homolog 3 inhibitor | 0.028 0.004 DBMET02419 0.021 0.004 DBMET02420 0.016 0.005 DBMET02421 | DBMET02419 | |
| 0.032 | 0.04 | 0.112 | Estradiol 17 beta-dehydrogenase inhibitor | 0.078 0.014 DBMET02419 0.112 0.009 DBMET02420 | DBMET02420 | |
| 0.024 | 0.033 | 0.027 | Hedgehog signaling activator | 0.027 0.019 DBMET02419 0.026 0.025 DBMET02420 | DBMET02419 | |
| 0.008 | 0.017 | 0.027 | Thrombopoietin agonist | 0.027 0.004 DBMET02419 0.017 0.004 DBMET02420 | DBMET02419 | |
| 0.05 | 0.06 | 0.526 | Selectin antagonist | 0.526 0.002 DBMET02417 0.061 0.049 DBMET02419 0.067 0.044 DBMET02420 | DBMET02417 | |
| 0.022 | 0.033 | 0.027 | LFA antagonist | 0.027 0.021 DBMET02419 | DBMET02419 | |
| 0.089 | 0.1 | 0.093 | Factor V inhibitor | 0.093 0.088 DBMET02419 | DBMET02419 | |
| 0.025 | 0.036 | 0.04 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.038 0.016 DBMET02419 0.04 0.015 DBMET02420 | DBMET02420 | |
| 0.062 | 0.073 | 0.085 | Phospholipase D inhibitor | 0.085 0.028 DBMET02419 0.075 0.043 DBMET02420 0.076 0.041 DBMET02421 | DBMET02419 | |
| 0.02 | 0.031 | 0.03 | Lysine carboxypeptidase inhibitor | 0.03 0.016 DBMET02419 0.029 0.016 DBMET02420 0.03 0.015 DBMET02421 | DBMET02421 | |
| 0.088 | 0.1 | 0.204 | Protein kinase C gamma inhibitor | 0.179 0.019 DBMET02419 0.204 0.013 DBMET02420 | DBMET02420 | |
| 0.005 | 0.017 | 0.016 | Thyroid hormone beta agonist | 0.011 0.005 DBMET02419 0.016 0.004 DBMET02420 0.012 0.004 DBMET02421 | DBMET02420 | |
| 0.009 | 0.023 | 0.038 | Egl nine homolog 1 inhibitor | 0.038 0.004 DBMET02419 0.03 0.004 DBMET02420 0.034 0.004 DBMET02421 | DBMET02419 | |
| 0.079 | 0.093 | 0.103 | Lanosterol 14 alpha demethylase inhibitor | 0.103 0.051 DBMET02419 0.09 0.072 DBMET02420 | DBMET02419 | |
| 0.028 | 0.042 | 0.069 | Protein kinase (CK2) beta inhibitor | 0.069 0.005 DBMET02419 0.068 0.005 DBMET02420 | DBMET02419 | |
| 0.021 | 0.035 | 0.159 | Sodium/glucose cotransporter inhibitor | 0.159 0.002 DBMET02417 0.026 0.018 DBMET02419 0.025 0.018 DBMET02420 | DBMET02417 | |
| 0.036 | 0.049 | 0.042 | GABA B receptor antagonist | 0.042 0.031 DBMET02419 | DBMET02419 | |
| 0.025 | 0.04 | 0.046 | Catechol O-methyltransferase inhibitor | 0.036 0.018 DBMET02419 0.046 0.01 DBMET02420 | DBMET02420 | |
| 0.036 | 0.051 | 0.043 | Guanylate cyclase stimulant | 0.043 0.031 DBMET02419 | DBMET02419 | |
| 0.006 | 0.021 | 0.02 | Beta 3 adrenoreceptor agonist | 0.018 0.005 DBMET02419 0.02 0.005 DBMET02420 | DBMET02420 | |
| 0.02 | 0.036 | 0.139 | Sodium/glucose cotransporter 2 inhibitor | 0.139 0.002 DBMET02417 0.028 0.016 DBMET02419 0.028 0.016 DBMET02420 | DBMET02417 | |
| 0.044 | 0.06 | 0.052 | Vanilloid 2 antagonist | 0.052 0.038 DBMET02420 | DBMET02420 | |
| 0.047 | 0.063 | 0.058 | Botulinum neurotoxin type A inhibitor | 0.058 0.041 DBMET02419 | DBMET02419 | |
| 0.067 | 0.084 | 0.137 | Histamine N-methyltransferase inhibitor | 0.137 0.02 DBMET02419 0.129 0.024 DBMET02420 | DBMET02419 | |
| 0.05 | 0.067 | 0.063 | Potassium channel intermediate-conductance Ca-activated blocker | 0.063 0.036 DBMET02419 | DBMET02419 | |
| 0.011 | 0.028 | 0.015 | Thromboxane A2 agonist | 0.015 0.012 DBMET02419 | DBMET02419 | |
| 0.033 | 0.051 | 0.084 | Glutamate (mGluR group III) agonist | 0.084 0.012 DBMET02419 0.075 0.014 DBMET02420 | DBMET02419 | |
| 0.154 | 0.173 | 0.177 | Calpain inhibitor | 0.177 0.139 DBMET02419 0.162 0.16 DBMET02420 | DBMET02419 | |
| 0.112 | 0.132 | 0.487 | NOS3 expression enhancer | 0.487 0.005 DBMET02417 0.199 0.041 DBMET02419 0.275 0.022 DBMET02420 | DBMET02417 | |
| 0.055 | 0.075 | 0.079 | Beta 3 adrenoreceptor antagonist | 0.075 0.027 DBMET02419 0.079 0.024 DBMET02420 | DBMET02420 | |
| 0.008 | 0.029 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.009 DBMET02419 0.012 0.011 DBMET02420 0.016 0.005 DBMET02421 | DBMET02421 | |
| 0.02 | 0.041 | 0.029 | Liver X receptor antagonist | 0.029 0.024 DBMET02420 | DBMET02420 | |
| 0.013 | 0.035 | 0.025 | Corticosteroid-like | 0.025 0.01 DBMET02417 | DBMET02417 | |
| 0.033 | 0.055 | 0.053 | Thymidylate synthase inhibitor | 0.053 0.024 DBMET02419 0.047 0.032 DBMET02420 0.044 0.036 DBMET02421 | DBMET02419 | |
| 0.026 | 0.05 | 0.044 | Glutamate (mGluR4) agonist | 0.044 0.013 DBMET02419 0.04 0.016 DBMET02420 | DBMET02419 | |
| 0.011 | 0.035 | 0.023 | Kainate receptor 5 antagonist | 0.023 0.013 DBMET02419 | DBMET02419 | |
| 0.063 | 0.088 | 0.273 | Cell adhesion molecule inhibitor | 0.273 0.005 DBMET02417 | DBMET02417 | |
| 0.031 | 0.057 | 0.037 | Thymidine kinase inhibitor | 0.037 0.036 DBMET02419 | DBMET02419 | |
| 0.052 | 0.078 | 0.077 | Phosphodiesterase 1C inhibitor | 0.077 0.022 DBMET02419 0.067 0.033 DBMET02420 | DBMET02419 | |
| 0.089 | 0.115 | 0.107 | Tubulin antagonist | 0.107 0.094 DBMET02420 | DBMET02420 | |
| 0.014 | 0.041 | 0.042 | Somatostatin 5 antagonist | 0.029 0.024 DBMET02419 0.042 0.017 DBMET02420 | DBMET02420 | |
| 0.103 | 0.13 | 0.142 | Neurotrophic factor | 0.128 0.084 DBMET02419 0.142 0.066 DBMET02420 | DBMET02420 | |
| 0.053 | 0.084 | 0.072 | Transcription factor RelA inhibitor | 0.069 0.032 DBMET02419 0.072 0.026 DBMET02420 | DBMET02420 | |
| 0.017 | 0.048 | 0.024 | ICAM 1 antagonist | 0.024 0.014 DBMET02419 0.023 0.016 DBMET02420 | DBMET02419 | |
| 0.146 | 0.178 | 0.37 | Streptokinase A inhibitor | 0.37 0.056 DBMET02419 0.355 0.06 DBMET02420 | DBMET02419 | |
| 0.014 | 0.047 | 0.042 | AMPA 3 receptor antagonist | 0.042 0.013 DBMET02419 0.035 0.017 DBMET02420 | DBMET02419 | |
| 0.03 | 0.063 | 0.06 | Ribonucleoside-diphosphate reductase inhibitor | 0.053 0.038 DBMET02419 0.06 0.034 DBMET02420 0.059 0.035 DBMET02421 | DBMET02420 | |
| 0.009 | 0.042 | 0.035 | Thyroid hormone alpha antagonist | 0.026 0.005 DBMET02419 0.035 0.005 DBMET02420 0.026 0.005 DBMET02421 | DBMET02420 | |
| 0.16 | 0.194 | 0.194 | Thyroid hormone beta antagonist | 0.194 0.159 DBMET02419 0.188 0.165 DBMET02420 | DBMET02419 | |
| 0.027 | 0.061 | 0.045 | Protein kinase C beta I inhibitor | 0.032 0.029 DBMET02417 0.041 0.008 DBMET02419 0.045 0.005 DBMET02420 | DBMET02420 | |
| 0.03 | 0.065 | 0.061 | Ribonucleotide reductase inhibitor | 0.054 0.04 DBMET02419 0.061 0.036 DBMET02420 0.061 0.036 DBMET02421 | DBMET02421 | |
| 0.135 | 0.171 | 0.212 | Histone acetyltransferase inhibitor | 0.209 0.056 DBMET02419 0.212 0.052 DBMET02420 | DBMET02420 | |
| 0.033 | 0.069 | 0.179 | Protein 50S ribosomal subunit inhibitor | 0.179 0.005 DBMET02417 | DBMET02417 | |
| 0.037 | 0.074 | 0.053 | Bombesin 2 receptor antagonist | 0.05 0.033 DBMET02419 0.053 0.03 DBMET02420 | DBMET02420 | |
| 0.045 | 0.083 | 0.179 | NMDA 2 receptor antagonist | 0.179 0.011 DBMET02419 0.172 0.012 DBMET02420 | DBMET02419 | |
| 0.02 | 0.058 | 0.044 | Toll-Like receptor 4 agonist | 0.044 0.004 DBMET02417 | DBMET02417 | |
| 0.038 | 0.076 | 0.129 | Purinergic P2X2 antagonist | 0.081 0.04 DBMET02419 0.129 0.017 DBMET02420 | DBMET02420 | |
| 0.011 | 0.049 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.03 0.018 DBMET02417 | DBMET02417 | |
| 0.023 | 0.063 | 0.039 | Toll-Like receptor 2 agonist | 0.039 0.03 DBMET02417 | DBMET02417 | |
| 0.064 | 0.105 | 0.083 | Histamine H2 receptor antagonist | 0.082 0.061 DBMET02419 0.083 0.059 DBMET02420 | DBMET02420 | |
| 0.074 | 0.116 | 0.321 | Estrogen receptor beta antagonist | 0.155 0.014 DBMET02419 0.321 0.005 DBMET02420 0.096 0.072 DBMET02421 | DBMET02420 | |
| 0.006 | 0.048 | 0.016 | Purinergic P2Y2 agonist | 0.016 0.003 DBMET02417 | DBMET02417 | |
| 0.06 | 0.104 | 0.073 | Vanilloid 4 agonist | 0.073 0.057 DBMET02419 | DBMET02419 | |
| 0.009 | 0.055 | 0.044 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.029 0.012 DBMET02419 0.044 0.008 DBMET02420 | DBMET02420 | |
| 0.003 | 0.049 | 0.022 | Antibiotic Macrolide-like | 0.022 0.006 DBMET02417 | DBMET02417 | |
| 0.035 | 0.081 | 0.041 | Heme oxygenase inhibitor | 0.041 0.04 DBMET02419 | DBMET02419 | |
| 0.071 | 0.117 | 0.118 | T cell inhibitor | 0.118 0.015 DBMET02417 | DBMET02417 | |
| 0.013 | 0.059 | 0.042 | Dopamine D1 agonist | 0.042 0.005 DBMET02417 | DBMET02417 | |
| 0.026 | 0.072 | 0.045 | Nicotinic acid receptor 1 agonist | 0.045 0.024 DBMET02419 0.042 0.026 DBMET02420 | DBMET02419 | |
| 0.03 | 0.077 | 0.085 | Beta tubulin antagonist | 0.085 0.027 DBMET02420 | DBMET02420 | |
| 0.098 | 0.145 | 0.343 | Anticoagulant | 0.343 0.022 DBMET02417 | DBMET02417 | |
| 0.097 | 0.146 | 0.128 | Acetylcholine M1 receptor antagonist | 0.128 0.098 DBMET02419 0.118 0.111 DBMET02420 | DBMET02419 | |
| 0.022 | 0.073 | 0.046 | Oxytocin agonist | 0.043 0.029 DBMET02419 0.046 0.027 DBMET02420 | DBMET02420 | |
| 0.007 | 0.06 | 0.042 | AMPA 1 receptor antagonist | 0.042 0.014 DBMET02419 0.039 0.015 DBMET02420 | DBMET02419 | |
| 0.015 | 0.068 | 0.128 | Protocollagen prolyl hydroxylase inhibitor | 0.043 0.007 DBMET02419 0.039 0.008 DBMET02420 0.128 0.004 DBMET02421 | DBMET02421 | |
| 0.066 | 0.121 | 0.096 | mTOR complex 2 inhibitor | 0.096 0.039 DBMET02419 0.09 0.047 DBMET02420 | DBMET02419 | |
| 0.009 | 0.064 | 0.02 | Thyroid hormone alpha agonist | 0.019 0.008 DBMET02419 0.02 0.006 DBMET02420 0.02 0.007 DBMET02421 | DBMET02421 | |
| 0.035 | 0.093 | 0.082 | Cytokine production stimulant | 0.082 0.005 DBMET02417 0.046 0.043 DBMET02419 | DBMET02417 | |
| 0.155 | 0.215 | 0.258 | Thioredoxin glutathione reductase inhibitor | 0.258 0.129 DBMET02419 0.237 0.143 DBMET02420 | DBMET02419 | |
| 0.038 | 0.1 | 0.065 | HIV-1 reverse transcriptase inhibitor | 0.06 0.059 DBMET02419 0.065 0.054 DBMET02420 | DBMET02420 | |
| 0.055 | 0.117 | 0.104 | MAO A inhibitor | 0.097 0.066 DBMET02419 0.104 0.061 DBMET02420 | DBMET02420 | |
| 0.011 | 0.076 | 0.029 | CXC chemokine 2 receptor antagonist | 0.029 0.015 DBMET02419 | DBMET02419 | |
| 0.036 | 0.104 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.047 DBMET02419 | DBMET02419 | |
| 0.042 | 0.11 | 0.106 | Protein kinase C beta inhibitor | 0.093 0.017 DBMET02419 0.106 0.011 DBMET02420 | DBMET02420 | |
| 0.04 | 0.109 | 0.077 | DNA gyrase inhibitor | 0.077 0.029 DBMET02417 0.065 0.042 DBMET02419 0.066 0.04 DBMET02420 | DBMET02417 | |
| 0.015 | 0.085 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.034 0.007 DBMET02417 | DBMET02417 | |
| 0.161 | 0.231 | 0.215 | Calpain 2 inhibitor | 0.215 0.175 DBMET02419 | DBMET02419 | |
| 0.019 | 0.089 | 0.042 | Alpha 1d adrenoreceptor agonist | 0.038 0.028 DBMET02419 0.042 0.023 DBMET02420 | DBMET02420 | |
| 0.066 | 0.137 | 0.14 | MAO inhibitor | 0.131 0.069 DBMET02419 0.14 0.065 DBMET02420 | DBMET02420 | |
| 0.026 | 0.098 | 0.062 | Alpha tubulin antagonist | 0.062 0.029 DBMET02420 | DBMET02420 | |
| 0.059 | 0.132 | 0.089 | Aminoacyl-tRNA synthetase inhibitor | 0.087 0.063 DBMET02419 0.089 0.06 DBMET02420 | DBMET02420 | |
| 0.034 | 0.109 | 0.053 | Sphingosine kinase 2 inhibitor | 0.051 0.044 DBMET02419 0.053 0.042 DBMET02420 | DBMET02420 | |
| 0.108 | 0.184 | 0.218 | I kappa B kinase epsilon inhibitor | 0.217 0.058 DBMET02419 0.218 0.057 DBMET02420 | DBMET02420 | |
| 0.019 | 0.097 | 0.048 | Ceramide glucosyltransferase inhibitor | 0.048 0.009 DBMET02417 | DBMET02417 | |
| 0.152 | 0.231 | 0.588 | Immunomodulator | 0.588 0.013 DBMET02417 | DBMET02417 | |
| 0.044 | 0.123 | 0.125 | MAO B inhibitor | 0.119 0.051 DBMET02419 0.125 0.048 DBMET02420 | DBMET02420 | |
| 0.02 | 0.099 | 0.06 | AMPA receptor antagonist | 0.06 0.025 DBMET02419 0.048 0.033 DBMET02420 | DBMET02419 | |
| 0.035 | 0.114 | 0.051 | Epithelial sodium channel blocker | 0.051 0.046 DBMET02419 0.051 0.046 DBMET02420 | DBMET02420 | |
| 0.028 | 0.108 | 0.045 | Cholesterol esterase inhibitor | 0.045 0.038 DBMET02419 | DBMET02419 | |
| 0.042 | 0.122 | 0.155 | Histone deacetylase SIRT1 stimulant | 0.155 0.008 DBMET02417 0.07 0.054 DBMET02419 0.105 0.025 DBMET02420 | DBMET02417 | |
| 0.042 | 0.122 | 0.155 | Histone deacetylase stimulant | 0.155 0.008 DBMET02417 0.07 0.054 DBMET02419 0.105 0.025 DBMET02420 | DBMET02417 | |
| 0.049 | 0.132 | 0.095 | Phosphodiesterase VI inhibitor | 0.095 0.024 DBMET02417 | DBMET02417 | |
| 0.046 | 0.131 | 0.09 | Somatostatin 1 agonist | 0.084 0.047 DBMET02419 0.09 0.041 DBMET02420 | DBMET02420 | |
| 0.006 | 0.093 | 0.18 | Estrogen receptor beta agonist | 0.052 0.019 DBMET02417 0.074 0.015 DBMET02419 0.18 0.005 DBMET02420 | DBMET02420 | |
| 0.053 | 0.142 | 0.083 | Potassium channel activator | 0.083 0.071 DBMET02419 | DBMET02419 | |
| 0.064 | 0.153 | 0.094 | MAP kinase kinase 1 inhibitor | 0.094 0.065 DBMET02419 0.086 0.077 DBMET02420 | DBMET02419 | |
| 0.029 | 0.12 | 0.057 | Myc inhibitor | 0.057 0.033 DBMET02419 0.054 0.038 DBMET02420 | DBMET02419 | |
| 0.03 | 0.123 | 0.132 | Factor IXa inhibitor | 0.132 0.005 DBMET02417 0.057 0.029 DBMET02419 0.047 0.043 DBMET02420 | DBMET02417 | |
| 0.034 | 0.13 | 0.061 | Glucosylceramidase inhibitor | 0.06 0.031 DBMET02417 0.061 0.03 DBMET02419 0.051 0.045 DBMET02420 | DBMET02419 | |
| 0.094 | 0.191 | 0.144 | Neuropeptide Y1 antagonist | 0.142 0.078 DBMET02419 0.144 0.074 DBMET02420 | DBMET02420 | |
| 0.009 | 0.11 | 0.033 | Sirtuin 2 inhibitor | 0.033 0.022 DBMET02419 | DBMET02419 | |
| 0.031 | 0.132 | 0.081 | Lipase inhibitor | 0.076 0.048 DBMET02419 0.081 0.042 DBMET02420 | DBMET02420 | |
| 0.056 | 0.159 | 0.308 | M18 aspartyl aminopeptidase inhibitor | 0.255 0.02 DBMET02419 0.308 0.012 DBMET02420 0.121 0.069 DBMET02421 | DBMET02420 | |
| 0.034 | 0.141 | 0.055 | Phosphodiesterase 1B inhibitor | 0.055 0.049 DBMET02419 | DBMET02419 | |
| 0.061 | 0.171 | 0.091 | Hematopoietic | 0.091 0.047 DBMET02419 0.085 0.06 DBMET02420 0.081 0.069 DBMET02421 | DBMET02419 | |
| 0.018 | 0.132 | 0.045 | Estrogen-related receptor beta antagonist | 0.034 0.018 DBMET02419 0.045 0.007 DBMET02420 | DBMET02420 | |
| 0.062 | 0.177 | 0.084 | CC chemokine 5 receptor agonist | 0.084 0.05 DBMET02419 0.081 0.061 DBMET02420 | DBMET02419 | |
| 0.013 | 0.128 | 0.042 | Urokinase inhibitor | 0.042 0.037 DBMET02419 | DBMET02419 | |
| 0.091 | 0.208 | 0.162 | Papain-like protease (SARS coronavirus) inhibitor | 0.157 0.028 DBMET02419 0.162 0.025 DBMET02420 0.118 0.087 DBMET02421 | DBMET02420 | |
| 0.025 | 0.144 | 0.134 | Protein kinase C eta inhibitor | 0.105 0.016 DBMET02419 0.134 0.009 DBMET02420 | DBMET02420 | |
| 0.025 | 0.144 | 0.052 | Purinergic P2X4 antagonist | 0.052 0.023 DBMET02419 0.049 0.026 DBMET02420 | DBMET02419 | |
| 0.019 | 0.139 | 0.069 | Plasminogen activator inhibitor | 0.069 0.033 DBMET02419 0.057 0.042 DBMET02420 | DBMET02419 | |
| 0.004 | 0.124 | 0.119 | Estrogen receptor alpha agonist | 0.047 0.018 DBMET02419 0.119 0.007 DBMET02420 | DBMET02420 | |
| 0.057 | 0.18 | 0.125 | Glutamate receptor antagonist | 0.125 0.069 DBMET02419 0.119 0.074 DBMET02420 | DBMET02419 | |
| 0.035 | 0.164 | 0.067 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.06 0.042 DBMET02419 0.067 0.032 DBMET02420 | DBMET02420 | |
| 0.016 | 0.147 | 0.065 | Erythropoietin receptor agonist | 0.065 0.016 DBMET02421 | DBMET02421 | |
| 0.015 | 0.148 | 0.043 | Protein kinase C beta II inhibitor | 0.036 0.015 DBMET02419 0.043 0.009 DBMET02420 | DBMET02420 | |
| 0.014 | 0.147 | 0.043 | Opioid mu receptor agonist | 0.043 0.036 DBMET02420 | DBMET02420 | |
| 0.012 | 0.146 | 0.045 | Estrogen-related receptor alpha antagonist | 0.045 0.015 DBMET02420 | DBMET02420 | |
| 0.048 | 0.184 | 0.206 | DNA intercalator | 0.206 0.024 DBMET02417 | DBMET02417 | |
| 0.019 | 0.164 | 0.109 | Antibiotic Aminoglycoside-like | 0.109 0.003 DBMET02417 | DBMET02417 | |
| 0.008 | 0.153 | 0.102 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.056 0.013 DBMET02419 0.102 0.005 DBMET02420 | DBMET02420 | |
| 0.002 | 0.15 | 0.011 | Purinergic P2Y agonist | 0.011 0.01 DBMET02417 | DBMET02417 | |
| 0.03 | 0.18 | 0.069 | Sirtuin 1 inhibitor | 0.069 0.046 DBMET02419 0.067 0.048 DBMET02420 | DBMET02419 | |
| 0.078 | 0.228 | 0.176 | Sigma receptor agonist | 0.166 0.075 DBMET02419 0.176 0.071 DBMET02420 | DBMET02420 | |
| 0.047 | 0.201 | 0.081 | Phosphodiesterase I inhibitor | 0.081 0.075 DBMET02419 | DBMET02419 | |
| 0.002 | 0.161 | 0.015 | Purinergic P2 agonist | 0.015 0.011 DBMET02417 | DBMET02417 | |
| 0.002 | 0.161 | 0.015 | Purinergic receptor agonist | 0.015 0.011 DBMET02417 | DBMET02417 | |
| 0.029 | 0.206 | 0.08 | Bcr-Abl kinase inhibitor | 0.074 0.073 DBMET02419 0.08 0.064 DBMET02420 | DBMET02420 | |
| 0.087 | 0.265 | 0.556 | Tumour necrosis factor alpha release inhibitor | 0.556 0.01 DBMET02417 | DBMET02417 | |
| 0.034 | 0.234 | 0.084 | Opioid antagonist | 0.084 0.064 DBMET02420 | DBMET02420 | |
| 0.075 | 0.277 | 0.315 | Interleukin 6 antagonist | 0.315 0.013 DBMET02417 | DBMET02417 | |
| 0.042 | 0.247 | 0.111 | Protein kinase C zeta inhibitor | 0.1 0.051 DBMET02419 0.111 0.039 DBMET02420 | DBMET02420 | |
| 0.09 | 0.299 | 0.193 | 5 Hydroxytryptamine 1E antagonist | 0.193 0.139 DBMET02419 0.188 0.145 DBMET02420 | DBMET02419 | |
| 0.013 | 0.226 | 0.07 | Opioid delta receptor antagonist | 0.07 0.04 DBMET02420 | DBMET02420 | |
| 0.014 | 0.23 | 0.062 | Opioid mu receptor antagonist | 0.062 0.052 DBMET02420 | DBMET02420 | |
| 0.023 | 0.246 | 0.062 | CXC chemokine 1 receptor antagonist | 0.062 0.02 DBMET02421 | DBMET02421 | |
| 0.082 | 0.315 | 0.271 | Cardiotonic | 0.271 0.069 DBMET02421 | DBMET02421 | |
| 0.008 | 0.241 | 0.044 | Factor Xa inhibitor | 0.044 0.034 DBMET02417 | DBMET02417 | |
| 0.037 | 0.272 | 0.092 | 5 Hydroxytryptamine 3A agonist | 0.092 0.086 DBMET02420 | DBMET02420 | |
| 0.052 | 0.292 | 0.163 | Interleukin 12 antagonist | 0.163 0.009 DBMET02417 0.088 0.078 DBMET02419 0.111 0.039 DBMET02420 | DBMET02417 | |
| 0.085 | 0.328 | 0.153 | MAP kinase kinase 4 inhibitor | 0.145 0.073 DBMET02419 0.153 0.055 DBMET02420 | DBMET02420 | |
| 0.032 | 0.278 | 0.098 | Bronchodilator | 0.098 0.066 DBMET02420 | DBMET02420 | |
| 0.038 | 0.284 | 0.128 | Histone deacetylase class III inhibitor | 0.102 0.088 DBMET02419 0.128 0.063 DBMET02420 | DBMET02420 | |
| 0.008 | 0.259 | 0.089 | Protein 30S ribosomal subunit inhibitor | 0.089 0.004 DBMET02417 | DBMET02417 | |
| 0.024 | 0.308 | 0.07 | Bcl2 antagonist | 0.07 0.043 DBMET02421 | DBMET02421 | |
| 0.051 | 0.339 | 0.148 | MAP kinase kinase 2 inhibitor | 0.148 0.123 DBMET02419 0.137 0.134 DBMET02420 | DBMET02419 | |
| 0.04 | 0.331 | 0.221 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.163 0.119 DBMET02419 0.221 0.081 DBMET02420 | DBMET02420 | |
| 0.078 | 0.389 | 0.359 | Angiogenesis inhibitor | 0.359 0.067 DBMET02417 | DBMET02417 | |
| 0.046 | 0.375 | 0.133 | Histone deacetylase SIRT1 inhibitor | 0.133 0.077 DBMET02420 | DBMET02420 | |
| 0.032 | 0.373 | 0.199 | Dyrk kinase inhibitor | 0.145 0.141 DBMET02419 0.199 0.099 DBMET02420 | DBMET02420 | |
| 0.077 | 0.432 | 0.304 | Antiobesity | 0.304 0.114 DBMET02417 | DBMET02417 | |
| 0.005 | 0.383 | 0.016 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.016 0.009 DBMET02417 | DBMET02417 | |
| 0.004 | 0.389 | 0.022 | Adenosine A1 receptor agonist | 0.022 0.02 DBMET02417 | DBMET02417 | |
| 0.005 | 0.393 | 0.019 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.019 0.008 DBMET02417 | DBMET02417 | |
| 0.023 | 0.446 | 0.137 | Multidrug resistance-associated protein 1 inhibitor | 0.137 0.033 DBMET02417 | DBMET02417 | |
| 0.004 | 0.708 | 0.036 | Motilin receptor agonist | 0.036 0.008 DBMET02417 | DBMET02417 | |
| 0.01 | 0.765 | 0.145 | Falcipain 2 inhibitor | 0.145 0.031 DBMET02417 | DBMET02417 | |
| 0.01 | 0.767 | 0.148 | Falcipain inhibitor | 0.148 0.032 DBMET02417 | DBMET02417 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |